<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006593.pub2" GROUP_ID="PREG" ID="527606112115490719" MERGED_FROM="" MODIFIED="2009-05-13 11:41:50 +0200" MODIFIED_BY="Frances Kellie" NOTES="&lt;p&gt;Exported from Review Manager 4.3.1&lt;br&gt;Exported from Review Manager 4.2.10&lt;br&gt;Exported from Review Manager 4.3&lt;br&gt;Exported from Review Manager 4.2.10&lt;br&gt;Exported from Review Manager 4.3&lt;br&gt;Exported from Review Manager 4.2.10&lt;br&gt;Exported from Review Manager 4.3.1&lt;br&gt;Exported from Review Manager 4.3&lt;br&gt;Exported from Review Manager 4.2.9&lt;br&gt;Exported from Review Manager 4.3&lt;br&gt;Exported from Review Manager 4.2.9&lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2009-05-13 10:39:20 +0100" NOTES_MODIFIED_BY="[Empty name]" REVIEW_NO="0525" REVMAN_SUB_VERSION="5.0.20" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="3.2">
<COVER_SHEET MODIFIED="2009-05-13 11:41:50 +0200" MODIFIED_BY="Frances Kellie">
<TITLE>Amniotic fluid index versus single deepest vertical pocket as a screening test for preventing adverse pregnancy outcome</TITLE>
<CONTACT MODIFIED="2009-05-13 11:41:50 +0200" MODIFIED_BY="Frances Kellie"><PERSON ID="5E13113D82E26AA20178986B1BF20BE3" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Ashraf</FIRST_NAME><MIDDLE_INITIALS>F</MIDDLE_INITIALS><LAST_NAME>Nabhan</LAST_NAME><POSITION>Assistant Professor</POSITION><EMAIL_1>ashraf.nabhan@gmail.com</EMAIL_1><EMAIL_2>afnabhan@aol.com</EMAIL_2><MOBILE_PHONE>+20 123317347</MOBILE_PHONE><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynecology</DEPARTMENT><ORGANISATION>Ain Shams University</ORGANISATION><ADDRESS_1>16 Ali Fahmi Kamel Street</ADDRESS_1><ADDRESS_2>Heliopolis</ADDRESS_2><CITY>Cairo</CITY><ZIP>11351</ZIP><COUNTRY CODE="EG">Egypt</COUNTRY><PHONE_1>+20 2263 57966</PHONE_1><PHONE_2>+20 2264 47500</PHONE_2></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2009-05-13 11:41:50 +0200" MODIFIED_BY="Frances Kellie"><PERSON ID="5E13113D82E26AA20178986B1BF20BE3" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Ashraf</FIRST_NAME><MIDDLE_INITIALS>F</MIDDLE_INITIALS><LAST_NAME>Nabhan</LAST_NAME><POSITION>Assistant Professor</POSITION><EMAIL_1>ashraf.nabhan@gmail.com</EMAIL_1><EMAIL_2>afnabhan@aol.com</EMAIL_2><MOBILE_PHONE>+20 123317347</MOBILE_PHONE><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynecology</DEPARTMENT><ORGANISATION>Ain Shams University</ORGANISATION><ADDRESS_1>16 Ali Fahmi Kamel Street</ADDRESS_1><ADDRESS_2>Heliopolis</ADDRESS_2><CITY>Cairo</CITY><ZIP>11351</ZIP><COUNTRY CODE="EG">Egypt</COUNTRY><PHONE_1>+20 2263 57966</PHONE_1><PHONE_2>+20 2264 47500</PHONE_2></ADDRESS></PERSON><PERSON ID="38C3404182E26AA201BA4B54265E8038" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Yaser</FIRST_NAME><MIDDLE_INITIALS>A</MIDDLE_INITIALS><LAST_NAME>Abdelmoula</LAST_NAME><POSITION>Assistant Professor</POSITION><EMAIL_1>mahatarek2005@hotmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Radiology</DEPARTMENT><ORGANISATION>Ain Shams University</ORGANISATION><CITY>Cairo</CITY><COUNTRY CODE="EG">Egypt</COUNTRY></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2009-05-13 10:39:20 +0100" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="1" MONTH="5" YEAR="2009"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="31" MONTH="1" YEAR="2009"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="31" MONTH="5" YEAR="2010"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="2007"/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="2008"/>
<LAST_CITATION_ISSUE ISSUE="3" YEAR="2008"/>
</DATES>
<WHATS_NEW MODIFIED="2009-05-07 14:38:45 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2009-05-07 14:38:45 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="24" MONTH="3" YEAR="2009"/>
<DESCRIPTION>
<P>Search updated January 2009. No new trials identified. One trial (<LINK REF="STD-Oral-1999" TYPE="STUDY">Oral 1999</LINK>) previously identified as 'awaiting classification' has now been included. 'Summary of findings' table has been added and the 'Risk of bias' table has been expanded.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2009-04-07 09:03:38 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-04-07 09:03:38 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="27" MONTH="2" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2009-04-24 16:44:05 +0100" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES MODIFIED="2009-04-24 16:44:05 +0100" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2009-04-24 16:44:05 +0100" MODIFIED_BY="[Empty name]">
<NAME>Egyptian Center of Evidence Based Medicine</NAME>
<COUNTRY CODE="EG">Egypt</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2009-05-07 14:34:40 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2009-04-24 15:32:35 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2008-03-03 14:36:01 +0000" MODIFIED_BY="Denise Atherton">Amniotic fluid index compared with single deepest vertical pocket measurement in predicting an adverse pregnancy outcome</TITLE>
<SUMMARY_BODY MODIFIED="2009-04-24 15:32:35 +0100" MODIFIED_BY="[Empty name]">
<P>Amniotic fluid provides a supportive and protective environment for fetal development during pregnancy. A decreased amniotic fluid volume (oligohydramnios) can occur because of fetal anomalies, intrauterine growth restriction, pre-eclampsia or prolonged (post-term) pregnancy. Many caregivers practice planned delivery by induction of labor or caesarean section after diagnosis of decreased amniotic fluid volume at term, to prevent an adverse pregnancy outcome. Ultrasonography is non-invasive and is used widely for the follow up of pregnancy. It can be used to determine amniotic fluid volume by measuring either the amniotic fluid index or single deepest vertical pocket. </P>
<P>This review demonstrated that using the amniotic fluid index increased the number of pregnant women who were diagnosed with oligohydramnios and induced for an abnormal fluid volume when compared with the deepest vertical pocket measure. The women also had a higher rate of caesarean section for so-called fetal distress. Yet the rate of admission to neonatal intensive care units and the occurrence of neonatal acidosis, an objective assessment of fetal well-being, were similar between the two groups. The other measured perinatal outcomes that were no different were a non-reassuring fetal heart rate tracing, the presence of meconium, or an Apgar score of less than 7 at five minutes. These conclusions were from five randomized controlled trials involving 3226 women with singleton pregnancies, reported on between 1997 and 2004. </P>
<P>The accurate assessment of amniotic fluid volume by ultrasonography can be influenced by an inexperienced operator, fetal position, the probability of a transient change, and the different ultrasound diagnostic criteria of an abnormal volume.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2009-04-07 10:31:36 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2008-03-18 11:21:34 +0000" MODIFIED_BY="Sonja Henderson">
<P>Amniotic fluid volume is an important parameter in the assessment of fetal well-being. Oligohydramnios occurs in many high-risk conditions and is associated with poor perinatal outcomes. Many caregivers practice planned delivery by induction of labor or caesarean section after diagnosis of decreased amniotic fluid volume at term. There is no clear consensus on the best method to assess amniotic fluid adequacy.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To compare the use of the amniotic fluid index with the single deepest vertical pocket measurement as a screening tool for decreased amniotic fluid volume in preventing adverse pregnancy outcome.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2009-04-01 20:19:47 +0100" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (January 2009), the Cochrane Central Register of Controlled Trials (CENTRAL) (<I>The Cochrane Library</I> 2008, Issue 4), MEDLINE (1966 to January 2008) and the metaRegister of Controlled Trials (December 2008). We handsearched the citation lists of relevant publications, review articles, and included studies.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2008-02-27 18:33:44 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trials involving women with a singleton pregnancy, whether at low or high risk, undergoing ultrasound measurement of amniotic fluid volume as part of antepartum assessment of fetal well-being that compared the amniotic fluid index and the single deepest vertical pocket measurement.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P>Both authors independently assessed eligibility and quality, and extracted the data.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2009-04-07 10:31:36 +0100" MODIFIED_BY="[Empty name]">
<P>Five trials (3226 women) met the inclusion criteria. There is no evidence that one method is superior to the other in the prevention of poor peripartum outcomes, including: admission to a neonatal intensive care unit (Risk Ratio (RR) 1.04; 95% Confidence Intervals (CI) 0.85 to 1.26); an umbilical artery pH of less than 7.1; the presence of meconium; an Apgar score of less than 7 at five minutes; or caesarean delivery. When the amniotic fluid index was used, significantly more cases of oligohydramnios were diagnosed (RR 2.39, 95% CI 1.73 to 3.28), and more women had inductions of labor (RR 1.92; 95% CI 1.50 to 2.46) and caesarean delivery for fetal distress (RR 1.46; 95% CI 1.08 to 1.96)</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2008-03-17 02:38:18 +0000" MODIFIED_BY="[Empty name]">
<P>The single deepest vertical pocket measurement in the assessment of amniotic fluid volume during fetal surveillance seems a better choice since the use of the amniotic fluid index increases the rate of diagnosis of oligohydramnios and the rate of induction of labor without improvement in peripartum outcomes. A systematic review of the diagnostic accuracy of both methods in detecting decreased amniotic fluid volume is required.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2009-05-07 14:34:40 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2008-02-27 23:02:36 +0000" MODIFIED_BY="Ashraf F Nabhan">
<CONDITION MODIFIED="2008-03-18 11:22:15 +0000" MODIFIED_BY="Sonja Henderson">
<P>Amniotic fluid provides a supportive environment for fetal development. It protects the fetus from trauma and infection through its dampening and bacteriostatic properties. It allows for fetal movement and thus fosters the development of the fetal musculoskeletal system. It prevents compression of the umbilical cord and placenta and thus protects the fetus from vascular and nutritional compromise. Amniotic fluid is maintained in a dynamic equilibrium; its volume is the sum of fluid (from fetal urine and lung fluid) flowing into and out (to fetal swallowing and intramembranous absorption) of the amniotic space (<LINK REF="REF-Ross-2001" TYPE="REFERENCE">Ross 2001</LINK>). Amniotic fluid volume (AFV) is an important parameter in the assessment of fetal well-being. Oligohydramnios, a decreased AFV, occurs as a result of fetal anomalies, intrauterine growth restriction, prolonged (post-term) pregnancies, and pre-eclampsia. Oligohydramnios is associated with increased fetal and neonatal morbidity and mortality (<LINK REF="REF-Sherer-2002" TYPE="REFERENCE">Sherer 2002</LINK>). Therefore, the prenatal diagnosis of oligohydramnios is important in the management of pregnancy (<LINK REF="REF-Sherer-2002" TYPE="REFERENCE">Sherer 2002</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2008-03-18 11:22:23 +0000" MODIFIED_BY="Sonja Henderson">
<P>Invasive methods such as indicator dilution techniques are the most accurate measures of AFV, but are impractical for clinical use. Ultrasonography is non-invasive and hence it is used widely for the follow up of pregnancy. Additionally, it can be performed serially in cases of suspected abnormal AFV (<LINK REF="REF-Gramellini-2004" TYPE="REFERENCE">Gramellini 2004</LINK>). Several methods are used to assess amniotic fluid. The first method is a subjective assessment where the volume is described as average, above average, below average or scant (<LINK REF="REF-Goldstein-1988" TYPE="REFERENCE">Goldstein 1988</LINK>; <LINK REF="REF-Gramellini-2004" TYPE="REFERENCE">Gramellini 2004</LINK>; <LINK REF="REF-Williams-1993" TYPE="REFERENCE">Williams 1993</LINK>). However, the experience of the operator is essential for reliable results (<LINK REF="REF-Gramellini-2004" TYPE="REFERENCE">Gramellini 2004</LINK>). Semi-quantitative estimates of AFV include the measurement of an amniotic fluid pocket (<LINK REF="REF-Gramellini-2004" TYPE="REFERENCE">Gramellini 2004</LINK>; <LINK REF="REF-Williams-1993" TYPE="REFERENCE">Williams 1993</LINK>), the amniotic fluid index (AFI) (<LINK REF="REF-Gramellini-2004" TYPE="REFERENCE">Gramellini 2004</LINK>; <LINK REF="REF-Williams-1993" TYPE="REFERENCE">Williams 1993</LINK>), and the amniotic fluid distribution (<LINK REF="REF-Myles-2002" TYPE="REFERENCE">Myles 2002</LINK>).</P>
<P>The measurement of a single pocket of amniotic fluid varies among studies depending on the criteria used for decreased amniotic fluid. Different techniques include a 1 cm pocket in one plane (<LINK REF="REF-Bastide-1986" TYPE="REFERENCE">Bastide 1986</LINK>; <LINK REF="REF-Hill-1983" TYPE="REFERENCE">Hill 1983</LINK>; <LINK REF="REF-Magann-2000" TYPE="REFERENCE">Magann 2000</LINK>; <LINK REF="REF-Manning-1981" TYPE="REFERENCE">Manning 1981</LINK>). Another technique is measuring two perpendicular diameters with values of 1 x 1 cm pocket, 2 x 1 cm pocket, and finally 2 x 2 cm pocket used (<LINK REF="REF-Magann-2000" TYPE="REFERENCE">Magann 2000</LINK>). It has also been shown that the largest vertical pocket cut-off value of 2.7 cm does better than the AFI and the 2 cm largest vertical pocket rule in identifying those at risk for adverse peripartum outcome (<LINK REF="REF-Fischer-1993" TYPE="REFERENCE">Fischer 1993</LINK>). Another cut-off value for the largest vertical pocket is suggested to be 4 cm (<LINK REF="REF-Rogers-1999" TYPE="REFERENCE">Rogers 1999</LINK>). The two diameter pocket method is also used (<LINK REF="REF-Gramellini-2004" TYPE="REFERENCE">Gramellini 2004</LINK>; <LINK REF="REF-Jaba-2005" TYPE="REFERENCE">Jaba 2005</LINK>; <LINK REF="REF-Magann-1992" TYPE="REFERENCE">Magann 1992</LINK>), and a value less than 15 cm<SUP>2</SUP> has been used to identify cases of decreased amniotic fluid (<LINK REF="REF-Magann-1999a" TYPE="REFERENCE">Magann 1999a</LINK>; <LINK REF="REF-Magann-2000" TYPE="REFERENCE">Magann 2000</LINK>; <LINK REF="REF-Rogers-1999" TYPE="REFERENCE">Rogers 1999</LINK>). Also, another technique for assessment of an amniotic fluid pocket is finding the product of the length, width, and depth of the largest amniotic fluid pocket (<LINK REF="REF-Hashimoto-1987" TYPE="REFERENCE">Hashimoto 1987</LINK>). In order to calculate the AFI, the operator divides the uterine cavity into four quadrants. In each quadrant, the largest vertical diameter of a fluid pocket (not containing small fetal parts or loops of umbilical cord) is measured. The sum of these four measures provides a single value for the AFI (<LINK REF="REF-Phelan-1987" TYPE="REFERENCE">Phelan 1987</LINK>).<BR/>One study has defined the 50<SUP>th</SUP> percentile of AFI to be 12.4 in term pregnancy. The authors also defined the 5<SUP>th</SUP>, 10<SUP>th</SUP>, 90<SUP>th</SUP>, and 95<SUP>th</SUP> percentiles to be 8.1, 9.0, 13.5, and 14.4 respectively in term pregnancy. The fifth percentile serves as the lower limit of normal AFI for 28 to 42 weeks' gestation (<LINK REF="REF-Hinh-2005" TYPE="REFERENCE">Hinh 2005</LINK>).<BR/>
<BR/>Different arbitrary cut-off values for identifying oligohydramnios have been estimated to be 5 cm (<LINK REF="REF-Croom-1992" TYPE="REFERENCE">Croom 1992</LINK>; <LINK REF="REF-Magann-1999a" TYPE="REFERENCE">Magann 1999a</LINK>; <LINK REF="REF-Magann-2003" TYPE="REFERENCE">Magann 2003</LINK>; <LINK REF="REF-Seffah-1999" TYPE="REFERENCE">Seffah 1999</LINK>) or 8 cm (<LINK REF="REF-Garmel-1997" TYPE="REFERENCE">Garmel 1997</LINK>; <LINK REF="REF-Kawasaki-2002" TYPE="REFERENCE">Kawasaki 2002</LINK>; <LINK REF="REF-Peedicayil-1994" TYPE="REFERENCE">Peedicayil 1994</LINK>; <LINK REF="REF-Rogers-1999" TYPE="REFERENCE">Rogers 1999</LINK>).</P>
<P>Ultrasonographic assessment of amniotic fluid can be viewed as a semi-quantitative method. Moreover, there is also the question of reliability. Methods of assessing amniotic fluid perform best when identifying normal volumes, but are poor when identifying an abnormal volume (<LINK REF="REF-Gramellini-2004" TYPE="REFERENCE">Gramellini 2004</LINK>). In addition to the differences in the methods used to assess amniotic fluid, other factors play a role in the accurate assessment of amniotic fluid by ultrasonography. These include an inexperienced operator, fetal position, the probability of a transient change in AFV, and the different ultrasound diagnostic criteria of an abnormal AFV (<LINK REF="REF-Fok-2006" TYPE="REFERENCE">Fok 2006</LINK>; <LINK REF="REF-Sherer-2002" TYPE="REFERENCE">Sherer 2002</LINK>). Furthermore, there is no consensus on the method or the cut-off value that is more accurate in predicting perinatal morbidity and mortality (<LINK REF="REF-Magann-2000" TYPE="REFERENCE">Magann 2000</LINK>).</P>
<P>The AFI and the single deepest vertical pocket (SDVP) are the more commonly employed techniques for assessing adequacy of amniotic fluid. According to these two methods, an AFI less than or equal to 5.0 cm, or the absence of a pocket measuring 2 x 1 cm, can diagnose a decreased AFV (<LINK REF="REF-Magann-2003" TYPE="REFERENCE">Magann 2003</LINK>). A meta-analysis has concluded that a decreased AFI is associated with poor perinatal outcomes in terms of an increased caesarean delivery rate performed for fetal distress, a low Apgar score at five minutes, and neonatal acidosis (<LINK REF="REF-Chauhan-1999" TYPE="REFERENCE">Chauhan 1999</LINK>). Therefore, a decreased AFV has been viewed as a sign of potential fetal compromise (<LINK REF="REF-Casey-2000" TYPE="REFERENCE">Casey 2000</LINK>; <LINK REF="REF-Locatelli-2004" TYPE="REFERENCE">Locatelli 2004</LINK>). This is particularly the case for high-risk pregnancies.</P>
</INTERVENTION>
<IMPORTANCE MODIFIED="2008-02-27 23:02:15 +0000" MODIFIED_BY="Ashraf F Nabhan">
<P>Many caregivers practice planned delivery, either by induction of labor or caesarean delivery, following the diagnosis of a decreased AFV at term. However, there is no clear consensus on the best method to assess amniotic fluid (<LINK REF="REF-Magann-2000" TYPE="REFERENCE">Magann 2000</LINK>; <LINK REF="REF-Sherer-2002" TYPE="REFERENCE">Sherer 2002</LINK>). In other words, there is a lack of a gold standard test to detect decreased AFV. Randomised controlled trials (RCTs) have been conducted to compare the two most commonly used methods (i.e. the AFI versus the single deepest vertical pocket) and to determine the best technique to predict adverse pregnancy outcome among women undergoing antenatal testing. Nonetheless, to the best of our knowledge, a systematic review and meta-analysis of the published RCTs have not been conducted to address this practical issue. Therefore, there is a need for a systematic review and meta-analysis to compare the use of AFI with the 2 x 1 cm SDVP method in predicting adverse pregnancy outcome.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2008-03-18 11:22:24 +0000" MODIFIED_BY="Sonja Henderson">
<P>To compare the use of the AFI with the 2 x 1 cm SDVP as a screening tool for decreased AFV for the prevention of adverse perinatal outcomes, such as admission to neonatal intensive care unit and perinatal deaths.</P>
</OBJECTIVES>
<METHODS MODIFIED="2009-05-07 14:34:40 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA>
<CRIT_STUDIES>
<P>Randomised controlled trials.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Women with a singleton pregnancy, whether at low or high risk, undergoing tests for assessment of fetal well-being.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>Ultrasound measurement of AFV. The methods compared were the AFI and the 2 x 1 cm (single deepest vertical) pocket method.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2008-02-27 22:39:24 +0000" MODIFIED_BY="Ashraf F Nabhan">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2008-03-03 14:36:54 +0000" MODIFIED_BY="Denise Atherton">
<OL>
<LI>Admission to neonatal intensive care unit</LI>
<LI>Number of perinatal deaths</LI>
</OL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2008-03-18 11:22:26 +0000" MODIFIED_BY="Sonja Henderson">
<OL>
<LI>Rate of diagnosis of oligohydramnios (as defined by authors of each study)</LI>
<LI>Umbilical artery pH less than 7.1</LI>
<LI>Apgar score less than 7 at five minutes</LI>
<LI>Presence of meconium</LI>
<LI>Non-reassuring fetal heart rate tracing</LI>
<LI>Induction of labor</LI>
<LI>Assisted vaginal delivery (without specified indication)</LI>
<LI>Assisted vaginal delivery for fetal distress</LI>
<LI>Rate of caesarean section</LI>
<LI>Caesarean delivery for fetal distress</LI>
<LI>Length of neonatal intensive care unit stay</LI>
</OL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2009-04-01 20:19:10 +0100" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2009-04-01 20:19:10 +0100" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register by contacting the Trials Search Co-ordinator (January 2009).</P>
<P>The Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register is maintained by the Trials Search Co-ordinator and contains trials identified from:</P>
<OL>
<LI>quarterly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</LI>
<LI>weekly searches of MEDLINE;</LI>
<LI>handsearches of 30 journals and the proceedings of major conferences;</LI>
<LI>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts.</LI>
</OL>
<P>Details of the search strategies for CENTRAL and MEDLINE, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the &#8216;Specialized Register&#8217; section within the editorial information about the <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html">Cochrane Pregnancy and Childbirth Group</A>.</P>
<P>Trials identified through the searching activities described above are assigned to a review topic (or topics). The Trials Search Co-ordinator searches the register for each review using the topic list rather than keywords.</P>
<P>In addition, we searched CENTRAL (<I>The Cochrane Library</I> 2008, Issue 4), MEDLINE (January 1966 to December 2008) and the metaRegister of Controlled Trials (mRCT) (December 2008), using the search strategies detailed in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>
<BR/>
</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2008-03-18 14:09:01 +0000" MODIFIED_BY="Lynn Hampson">
<P>We handsearched the citation lists of relevant publications, review articles, and included studies.</P>
<P>We did not apply any language restrictions.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2009-05-07 14:34:40 +0100" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2009-04-24 16:16:55 +0100" MODIFIED_BY="[Empty name]">
<P>Both authors independently reviewed and assessed full text copies of all identified papers. There were no disagreements regarding eligibility for inclusion. The papers selected for the review met the inclusion criteria:<BR/>
</P>
<UL>
<LI>data presented on AFI and the 2 x 1 cm SDVP method for the assessment of AFV;</LI>
<LI>the total number of women treated was stated.</LI>
</UL>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2009-04-24 16:16:37 +0100" MODIFIED_BY="[Empty name]">
<P>We designed a form on which both authors independently recorded the extracted data. We used the Review Manager software (<LINK REF="REF-RevMan-2008" TYPE="REFERENCE">RevMan 2008</LINK>) to double enter all the data. When information regarding any of the above was unclear, we contacted the authors of the original reports to provide further details.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2009-05-06 12:56:53 +0100" MODIFIED_BY="[Empty name]">
<P>We assessed the validity of each study using the criteria outlined in the Cochrane Handbook for Systematic Reviews of Interventions (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>). We described the methods used for generation of the randomization sequence in the 'Characteristics of included studies' table.</P>
<SUBSECTION>
<HEADING LEVEL="4">(1) Sequence generation (checking for possible selection bias)</HEADING>
<P>We described for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups.</P>
<P>We assessed the method as:</P>
<UL>
<LI>adequate (any truly random process e.g. random number table; computer random number generator);</LI>
<LI>inadequate (any non random process e.g. odd or even date of birth; hospital or clinic record number);</LI>
<LI>unclear.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(2) Allocation concealment (checking for possible selection bias)</HEADING>
<P>We described for each included study the method used to conceal the allocation sequence in sufficient detail and determined whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>adequate (e.g. telephone or central randomization; consecutively numbered sealed opaque envelopes);</LI>
<LI>inadequate (open random allocation; unsealed or non-opaque envelopes, alternation; date of birth);</LI>
<LI>unclear.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(3) Blinding (checking for possible performance bias)</HEADING>
<P>We described for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. Studies were judged at low risk of bias if they were blinded, or if we judge that the lack of blinding could not have affected the results. Blinding was assessed separately for different outcomes or classes of outcomes.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>Blinding of participants (yes/no/unclear);</LI>
<LI>Blinding of caregiver (yes/no/unclear);</LI>
<LI>Blinding of outcome assessment (yes/no/unclear).</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(4) Incomplete outcome data (checking for possible attrition bias through withdrawals, dropouts, protocol deviations)</HEADING>
<P>We described for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We state whether attrition and exclusions were reported, the numbers included in the analysis at each stage (compared with the total randomized participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or was supplied by the trial authors, we re-included missing data in the analyses we undertook.</P>
<P>We assessed methods as:</P>
<UL>
<LI>adequate (less than 20% loss of participants);</LI>
<LI>inadequate (20% or more loss of participants);</LI>
<LI>unclear.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(5) Selective reporting bias</HEADING>
<P>We described for each included study how we investigated the possibility of selective outcome reporting bias and what we found.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>adequate (where it is clear that all of the study's prespecified outcomes and all the expected outcomes of interest to the review have been reported);</LI>
<LI>inadequate (where not all the study's prespecified outcomes have been reported; one or more reported primary outcomes were not prespecified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported);</LI>
<LI>unclear.</LI>
</UL>
</SUBSECTION>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2009-05-07 14:34:34 +0100" MODIFIED_BY="[Empty name]">
<P>We carried out statistical analysis using the Review Manager software (<LINK REF="REF-RevMan-2008" TYPE="REFERENCE">RevMan 2008</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">Dichotomous data </HEADING>
<P>For dichotomous data, we presented results as summary relative risk (RR) with 95% confidence intervals (CI).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Continuous data </HEADING>
<P>For continuous data, we used the mean difference.</P>
</SUBSECTION>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2009-05-07 14:34:40 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Cluster-randomized trials </HEADING>
<P>In the protocol, we planned to include cluster-randomized trials in the analyses along with individually randomized trials and to adjust their sample sizes using the methods described in <LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>. However, we did not identify any cluster randomized trials.</P>
</SUBSECTION>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2009-04-24 16:31:29 +0100" MODIFIED_BY="[Empty name]">
<P>We analyzed data on all participants with available data in the group to which they are allocated, regardless of whether or not they received the allocated intervention.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2009-05-06 12:57:37 +0100" MODIFIED_BY="[Empty name]">
<P>We applied tests of heterogeneity between trials using the I² statistic. I² values of more than 50% imply substantial heterogeneity (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>).</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2009-04-24 16:36:29 +0100" MODIFIED_BY="[Empty name]">
<P>Where we suspected reporting bias (see selective reporting bias above), we planned to contact study authors asking them to provide missing outcome data.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2009-04-24 16:35:48 +0100" MODIFIED_BY="[Empty name]">
<P>We used fixed-effect meta-analysis for combining data in the absence of significant heterogeneity if trials are sufficiently similar. If heterogeneity was found this was investigated followed by random-effects when appropriate.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2009-05-06 10:54:57 +0100" MODIFIED_BY="[Empty name]">
<P>We did not conduct subgroup analyses because none of the included studies assessed the methods of appraising AFV as a routine procedure for all pregnancies.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2009-04-24 16:17:29 +0100" MODIFIED_BY="[Empty name]">
<P>Our planned sensitivity analysis to explore the effect of trial quality was not required because none of the included trials had clearly 'inadequate' allocation of concealment.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2009-05-06 11:03:39 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2009-05-06 10:58:24 +0100" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2009-05-06 10:55:42 +0100" MODIFIED_BY="[Empty name]">
<P>The comprehensive literature search yielded 10 trials. Both review authors independently assessed the 10 full-text papers selected according to the inclusion and exclusion criteria indicated above.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2009-05-06 10:58:24 +0100" MODIFIED_BY="[Empty name]">
<P>Five RCTs met the inclusion criteria for this review (<LINK REF="STD-Alfirevic-1997" TYPE="STUDY">Alfirevic 1997</LINK>; <LINK REF="STD-Chauhan-2004" TYPE="STUDY">Chauhan 2004</LINK>; <LINK REF="STD-Magann-2004" TYPE="STUDY">Magann 2004</LINK>; <LINK REF="STD-Moses-2004" TYPE="STUDY">Moses 2004</LINK>; <LINK REF="STD-Oral-1999" TYPE="STUDY">Oral 1999</LINK>). These enrolled 3226 participants. There were 529 (16.4%) participants at a gestation of less than 37 weeks, 1431 (44.4%) at 37 to 40 weeks, and 1266 (39.2%) beyond 40 weeks. For details of the included studies, <I>see</I> the '<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>' table.</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2009-03-18 16:26:40 +0000" MODIFIED_BY="Ashraf F Nabhan">
<P>Five trials were excluded from the review (<I>see </I>'<LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>' table).</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2009-05-06 10:58:47 +0100" MODIFIED_BY="[Empty name]">
<P> </P>
<ALLOCATION MODIFIED="2009-05-06 10:24:04 +0100" MODIFIED_BY="[Empty name]">
<P>Regarding selection bias, included trial reports noted adequate concealment of allocation except the <LINK REF="STD-Oral-1999" TYPE="STUDY">Oral 1999</LINK> study in which the method of allocation concealment was unclear. Included trial reports noted adequate sequence generation, except <LINK REF="STD-Alfirevic-1997" TYPE="STUDY">Alfirevic 1997</LINK> in which the method of sequence generation was 'unclear'.</P>
</ALLOCATION>
<BLINDING MODIFIED="2009-03-18 16:29:08 +0000" MODIFIED_BY="Ashraf F Nabhan">
<P>In one trial (<LINK REF="STD-Moses-2004" TYPE="STUDY">Moses 2004</LINK>), the caregivers were blinded to the group assignment and the specific measurement; in the others, performance bias (blinding of participants, caregivers, and outcome assessment) was unclear.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2009-03-18 16:29:50 +0000" MODIFIED_BY="Ashraf F Nabhan">
<P>For attrition bias, all trials had a less than 5% participant loss</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2009-05-06 10:58:47 +0100" MODIFIED_BY="[Empty name]">
<P>None of the 5 included trials (including 3226 pregnant women) reported the length stay in the neonatal intensive care unit. There is no data provided in 2 trials regarding perinatal death (<LINK REF="STD-Magann-2004" TYPE="STUDY">Magann 2004</LINK>; <LINK REF="STD-Moses-2004" TYPE="STUDY">Moses 2004</LINK>).</P>
</SELECTIVE_REPORTING>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2009-05-06 11:03:39 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Primary outcome measures</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1. Admission to neonatal intensive care unit</HEADING>
<P>Rate of admission to a neonatal intensive care unit was reported in all five included trials (3226 pregnant women) and there was no evidence of a difference between the two groups (AFI and SDVP measurement) for this outcome (Risk Ratio (RR) 1.04, 95% Confidence Intervals (CI) 0.85 to 1.26, five trials, 3226 newborns) (see <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Number of perinatal deaths</HEADING>
<P>No perinatal deaths occurred in the three studies that reported this outcome measure (<LINK REF="STD-Alfirevic-1997" TYPE="STUDY">Alfirevic 1997</LINK>; <LINK REF="STD-Chauhan-2004" TYPE="STUDY">Chauhan 2004</LINK>; <LINK REF="STD-Oral-1999" TYPE="STUDY">Oral 1999</LINK>) (see <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Secondary outcome measures</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1. Rate of diagnosis of oligohydramnios</HEADING>
<P>The rate of diagnosis of oligohydramnios was higher when the AFI was used for fetal surveillance (RR) 2.39; 95% CI 1.73 to 3.28; five trials, 3226 pregnancies) (see <LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Ulbilical artery pH less than 7.1</HEADING>
<P>Umbilical artery pH less than 7.1: no evidence of a difference between the two groups (RR 1.10; 95% CI 0.74 to 1.65; three trials, 2625 newborns) (see <LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Apgar score less than 7 at five minutes</HEADING>
<P>Apgar score of less than 7 at five minutes: no evidence of a difference between the two groups (RR 1.15; 95% CI 0.70 to 1.89; five trials, 3226 newborns) (<LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4. Presence of meconium</HEADING>
<P>Presence of meconium: no evidence of a difference between the two groups (RR 1.09; 95% CI 0.90 to 1.30; five trials, 3226 newborns) (see <LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5. Non-reassuring fetal heart rate tracing</HEADING>
<P>Non-reassuring fetal heart rate tracing: no evidence of a difference between the two groups (RR 1.13; 95% CI 0.93 to 1.36; four trials, 2726 fetuses) (see <LINK REF="CMP-002.05" TYPE="ANALYSIS">Analysis 2.5</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">6. Induction of labour</HEADING>
<P>The rate of induction of labor was higher when AFI was used for fetal surveillance (RR 1.92; 95% CI 1.50 to 2.46; four trials, 2138 pregnancies) (see <LINK REF="CMP-002.06" TYPE="ANALYSIS">Analysis 2.6</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">7. Assisted vaginal delivery (without specified indication)</HEADING>
<P>Assisted vaginal delivery: no evidence of a difference between the two groups (RR 1.08; 95% CI 0.92 to 1.27; four trials, 3125 deliveries) (see <LINK REF="CMP-002.07" TYPE="ANALYSIS">Analysis 2.7</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">8. Assisted vaginal delivery for fetal distress</HEADING>
<P>Assisted vaginal delivery for fetal distress: no evidence of a difference between the two groups (RR 1.07, 95% CI 0.80 to 1.44; two trials, 1625 deliveries) (see <LINK REF="CMP-002.08" TYPE="ANALYSIS">Analysis 2.8</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">9. Rate of caesarean section</HEADING>
<P>Caesarean delivery: no evidence of a difference between the two groups (RR 1.09; 95% CI 0.92 to 1.29; five trials, 3226 deliveries) (see <LINK REF="CMP-002.09" TYPE="ANALYSIS">Analysis 2.9</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">10. Caesarean section for fetal distress</HEADING>
<P>Caesarean delivery for fetal distress was higher when the AFI was used for fetal surveillance (RR 1.46; 95% CI 1.08 to 1.96; five trials, 3226 deliveries) (see <LINK REF="CMP-002.10" TYPE="ANALYSIS">Analysis 2.10</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">11. Length of neonatal intensive care unit stay</HEADING>
<P>None of the trials reported length of stay in a neonatal intensive care unit.</P>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2009-05-06 11:36:06 +0100" MODIFIED_BY="[Empty name]">
<P>Various antepartum fetal surveillance tests have the aim of providing the obstetrician with a tool that guides intervention with the ultimate goal of preventing clear-cut adverse pregnancy outcomes. Both the biophysical profile (BPP) and the modified BPP (MBPP) include the assessment of AFV as an integral part of testing because decreased AFV (oligohydramnios) in a pregnancy without fetal renal agenesis or obstructive uropathy is believed to indicate a fetal response to chronic stress (<LINK REF="REF-Gramellini-2004" TYPE="REFERENCE">Gramellini 2004</LINK>; <LINK REF="REF-Sherer-2002" TYPE="REFERENCE">Sherer 2002</LINK>).</P>
<P>The most common techniques used to ensure that the amniotic fluid is adequate are the AFI (<LINK REF="REF-Phelan-1987" TYPE="REFERENCE">Phelan 1987</LINK>) and the SDVP measurement (<LINK REF="REF-Chamberlain-1984" TYPE="REFERENCE">Chamberlain 1984</LINK>). According to these two methods, an AFI of 5 cm or less, or the absence of a pocket measuring 2 x 1 cm is indicative of decreased AFV.<B>
<BR/>
</B>
</P>
<SUMMARY_OF_RESULTS MODIFIED="2008-03-18 11:25:13 +0000" MODIFIED_BY="Sonja Henderson">
<P>This meta-analysis has demonstrated that pregnant women are significantly more likely to be diagnosed with oligohydramnios, be induced for an abnormal fluid volume, and undergo a caesarean delivery for fetal distress if AFI is used for fetal assessment. The major outcomes of concern are admission to a neonatal intensive care unit, neonatal acidosis, the presence of meconium, perinatal death, and an Apgar score of less than 7 at five minutes, all of which were similar in both groups. A higher rate of obstetric intervention can be justified only if there is a demonstrable decrease in the rate of poor pregnancy outcomes. Identifying a pregnant woman as having an oligohydramnios creates a form of the hoax effect, causing a higher number of inductions. This higher induction rate and a low threshold for the diagnosis of fetal distress led to a higher rate of caesarean section for so-called fetal distress in labor. <B>
<BR/>
</B>
</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2008-03-18 11:25:30 +0000" MODIFIED_BY="Sonja Henderson">
<P>The studies identified were sufficient to address all the objectives of this review. All our potential types of participants, interventions, and outcomes were investigated, except length of stay in a neonatal intensive care unit. This meta-analysis shows that, when comparing the use of AFI and SDVP, the AFI is associated with a higher rate of obstetric intervention without an improvement in pregnancy outcomes. This implies that the SDVP measurement is probably a better method to estimate AFV. The results of this meta-analysis should be interpreted with caution for two reasons. First, both methods have a poor sensitivity and specificity in detecting abnormal AFV. Second, multiple factors contribute to pregnancy outcomes in women undergoing antepartum fetal surveillance.</P>
<P>The results are important for current practice. Should the obstetrician base a clinical decision on the SDVP measurement or on the AFI? Today, some centres use the AFI and others the SDVP. A dilemma is evident when considering the two tests of antepartum assessment of fetal well-being: the BPP and the MBPP. In the BPP, the measurement of the single deepest pool is recorded in order to calculate the overall BPP score. In the MBPP, the AFI is used to assess the fluid volume. This is not merely an academic exercise or dilemma; it is a dilemma in our everyday practice. It is obviously confusing for caregivers when the same patient achieves a reassuring score of 10 for a BPP and then in the same file the sonographer describes the fluid as abnormal by using an AFI criterion.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2009-03-18 11:50:17 +0000" MODIFIED_BY="Ashraf F Nabhan">
<P>The trials included in this meta-analysis were of good quality with adequate allocation concealment. The analysis included five studies (3226 pregnancies). The results of the present meta-analysis are consistent among all the trials included in the analysis.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2009-03-18 11:50:31 +0000" MODIFIED_BY="Ashraf F Nabhan">
<P>We identified all relevant trials. We obtained all the relevant data.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2009-05-06 11:36:06 +0100" MODIFIED_BY="[Empty name]">
<P>The SDVP was routinely used to assess AFV until 1987, when Phelan and co-authors (<LINK REF="REF-Phelan-1987" TYPE="REFERENCE">Phelan 1987</LINK>) suggested that the AFI should be used instead. This first description of the technique was followed by reports by Rutherford et al. (<LINK REF="REF-Rutherford-1987a" TYPE="REFERENCE">Rutherford 1987a</LINK>; <LINK REF="REF-Rutherford-1987b" TYPE="REFERENCE">Rutherford 1987b</LINK>) and Sarno et al. (<LINK REF="REF-Sarno-1989" TYPE="REFERENCE">Sarno 1989</LINK>), which noted an increased rate of caesarean delivery for a non-reassuring fetal heart rate tracing and low Apgar scores in association with an AFI below the arbitrary cut-off point of 5 cm. This led to widespread adoption of the AFI as the method of choice for the assessment of amniotic fluid during antepartum fetal surveillance. This move can be criticized because of three important facts: reports have used subjective surrogate measures of neonatal morbidity; the incidence of neonatal acidosis, an objective assessment of fetal well-being, was not addressed in the early reports; and RCTs were not implemented to substantiate adoption of the AFI.<BR/>
<BR/>An early case control study showed that 72% of women with an AFI of 5 cm or less still had a SDVP measurement of greater than 2 cm (<LINK REF="REF-Magann-1999b" TYPE="REFERENCE">Magann 1999b</LINK>). Subsequently, RCTs have shown significantly greater numbers of women diagnosed as having oligohydramnios by measuring the AFI compared with the SDVP (<LINK REF="STD-Alfirevic-1997" TYPE="STUDY">Alfirevic 1997</LINK>; <LINK REF="STD-Chauhan-2004" TYPE="STUDY">Chauhan 2004</LINK>; <LINK REF="STD-Magann-2004" TYPE="STUDY">Magann 2004</LINK>; <LINK REF="STD-Moses-2004" TYPE="STUDY">Moses 2004</LINK>). This can be explained by the higher specificity of the SDVP measurement compared with the AFI in the assessment of decreased AFV.<BR/>
<BR/>The results of our meta-analysis show that the use of the AFI led to more diagnoses of oligohydramnios, more inductions of labor and caesarean deliveries for fetal distress without improving perinatal outcome. A recent study revealed that the criteria for determining the adequacy of amniotic fluid using the AFI are not diagnostically useful for identifying peripartum complications (<LINK REF="REF-Johnson-2007" TYPE="REFERENCE">Johnson 2007</LINK>). An earlier prospective double-blind cohort study also showed that the use of the AFI in pregnancies beyond 40 weeks, is likely to lead to increased obstetric intervention without improvement in perinatal outcomes (<LINK REF="REF-Morris-2003" TYPE="REFERENCE">Morris 2003</LINK>).</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS>
<IMPLICATIONS_PRACTICE>
<P>The use of the AFI increases the intervention rate without an improvement in pregnancy outcomes. The SDVP measurement appears to be the more appropriate method for assessing AFV during fetal surveillance. It is also logical to recommend that only one method should be used for fetal assessment tests.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2008-02-27 12:01:24 +0000" MODIFIED_BY="[Empty name]">
<P>A systematic review of the diagnostic accuracy of amniotic fluid index versus single deepest vertical pocket is needed. Further trials are warranted to reach a consensus and standardize the method to be used to detect a decreased AFV by means of the various tests for fetal well-being. The results of such trials and the consensus required would help to answer the question of when and how delivery should take place and reflect objective pregnancy outcomes.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2009-05-06 12:54:28 +0100" MODIFIED_BY="[Empty name]">
<P>The valuable contribution of Dr Susan Saad in supplying full-text articles is greatly appreciated.</P>
<P>We thank Dr. Nancy Santesso (Grade Working Group) for her professional help on the SoF Table.</P>
<P>We would not have been able to finish this work without the sincere help of the Cochrane Pregnancy and Childbirth Group's Managing Editor, Deputy Managing Editor, and Trials Search Co-ordinator.</P>
<P>We thank A Balistreri for providing translation of <LINK REF="STD-Oral-1999" TYPE="STUDY">Oral 1999</LINK>.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2009-04-24 16:45:18 +0100" MODIFIED_BY="[Empty name]">
<P>None known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2009-04-24 16:08:00 +0100" MODIFIED_BY="[Empty name]">
<P>AF Nabhan proposed the topic and wrote the protocol. YA Abdelmoula contributed to the development of the protocol and commented on drafts. Both authors independently assessed eligibility and quality, and extracted the data. Both authors collaborated in writing the full review. AF Nabhan created the summary of findings table. AF Nabhan updated the review and YA Abdelmoula commented on the update.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2009-04-07 10:57:51 +0100" MODIFIED_BY="[Empty name]">
<P>This updated review now incorporates the latest methods for assessing methodological quality of the included studies.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2009-05-06 12:56:14 +0100" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2009-04-01 20:26:00 +0100" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2009-04-01 20:26:00 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Alfirevic-1997" NAME="Alfirevic 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Alfirevic Z, Luckas M, Walkinshaw SA, McFarlane M, Curran R</AU>
<TI>A randomised comparison between amniotic fluid index and maximum pool depth in the monitoring of post-term pregnancy</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1997</YR>
<VL>104</VL>
<PG>207-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chauhan-2004" MODIFIED="2008-03-18 11:28:44 +0000" MODIFIED_BY="Sonja Henderson" NAME="Chauhan 2004" YEAR="2004">
<REFERENCE MODIFIED="2008-03-18 11:28:44 +0000" MODIFIED_BY="Sonja Henderson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chauhan SP, Doherty DD, Magann EF, Cahanding F, Moreno F, Klausen JH</AU>
<TI>Amniotic fluid index vs single deepest pocket technique during modified biophysical profile: a randomized clinical trial</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2004</YR>
<VL>191</VL>
<NO>2</NO>
<PG>661-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Magann-2004" NAME="Magann 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Magann E, Doherty D, Field K, Chauhan S, Muffley PE</AU>
<TI>Biophysical profile with amniotic fluid volume assessment: a randomized controlled trial of the amniotic fluid index versus single deepest pocket</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2003</YR>
<VL>189</VL>
<NO>6 Suppl 1</NO>
<PG>S179</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Magann EF, Doherty DA, Field K, Chauhan SP, Muffley PE, Morrison JC</AU>
<TI>Biophysical profile with amniotic fluid volume assessments</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2004</YR>
<VL>104</VL>
<NO>1</NO>
<PG>5-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moses-2004" NAME="Moses 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moses J, Doherty DA, Magann EF, Chauhan SP, Morrison JC</AU>
<TI>A randomized clinical trial of the intrapartum assessment of amniotic fluid volume: amniotic fluid index versus the single deepest pocket technique</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2004</YR>
<VL>190</VL>
<PG>1564-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Oral-1999" MODIFIED="2009-04-01 20:26:00 +0100" MODIFIED_BY="[Empty name]" NAME="Oral 1999" YEAR="1999">
<REFERENCE MODIFIED="2009-04-01 20:26:00 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Oral B, Gocen C, Ozbasar D</AU>
<TI>A comparison between two different ultrasonographic methods for assessing amniotic fluid volume in postterm pregnancies</TI>
<TO>Postterm gebeliklerde amniyotik sivi hacminin degerlendirilmesinde iki farkli ultrasonografi yonteminin karsilastirimasi</TO>
<SO>Ondokuz Mayis Universitesi Tip Dergisi</SO>
<YR>1999</YR>
<VL>16</VL>
<PG>180-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Alfirevic-1995" NAME="Alfirevic 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Alfirevic Z, Walkinshaw SA</AU>
<TI>A randomised controlled trial of simple compared with complex antenatal fetal monitoring after 42 weeks of gestation</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1995</YR>
<VL>102</VL>
<PG>638-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Callan-1996" NAME="Callan 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Callan FT, Jaekle RK, Karpel BM, Meyer BA</AU>
<TI>Amniotic fluid index: comparison of curvilinear and linear transducers</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1996</YR>
<VL>174</VL>
<NO>1 Pt 2</NO>
<PG>415</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chauhan-1995" NAME="Chauhan 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chauhan SP, Washburne JF, Magann EF, Perry KG, Martin JN, Morrison JC</AU>
<TI>A randomized study to assess the efficacy of the amniotic fluid index as a fetal admission test</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>1995</YR>
<VL>86</VL>
<PG>9-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Magann-1994" NAME="Magann 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Magann EF, Morton ML, Chauhan SP, Martin JN, Whitworth NS, Morrison JC</AU>
<TI>Accuracy of ultrasonic techniques for the evaluation of amniotic fluid volume in twins</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1994</YR>
<VL>170</VL>
<PG>365</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2009-03-18 11:33:14 +0000" MODIFIED_BY="Ashraf F Nabhan"/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2009-05-06 12:56:14 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2009-05-06 12:56:14 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Bastide-1986" NAME="Bastide 1986" NOTES="&lt;p&gt;0002-9378 (Print)&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Bastide A, Manning F, Harman C, Lange I, Morrison I</AU>
<TI>Ultrasound evaluation of amniotic fluid: outcome of pregnancies with severe oligohydramnios</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1986</YR>
<VL>154</VL>
<NO>4</NO>
<PG>895-900</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Casey-2000" NAME="Casey 2000" TYPE="JOURNAL_ARTICLE">
<AU>Casey BM, McIntire DD, Bloom SL, Lucas MJ, Santos R, Twickler DM, et al</AU>
<TI>Pregnancy outcomes after antepartum diagnosis of oligohydramnios at or beyond 34 weeks' gestation</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2000</YR>
<VL>182</VL>
<NO>4</NO>
<PG>909-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chamberlain-1984" NAME="Chamberlain 1984" TYPE="JOURNAL_ARTICLE">
<AU>Chamberlain PF, Manning FA, Morrison I, Harman CR, Lange IR</AU>
<TI>Ultrasound evaluation of amniotic fluid volume. I. The relationship of marginal and decreased amniotic fluid volumes to perinatal outcome</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1984</YR>
<VL>150</VL>
<NO>3</NO>
<PG>245-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chauhan-1999" NAME="Chauhan 1999" TYPE="JOURNAL_ARTICLE">
<AU>Chauhan SP, Sanderson M, Hendrix NW, Magann EF, Devoe LD</AU>
<TI>Perinatal outcome and amniotic fluid index in the antepartum and intrapartum periods: a meta-analysis</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1999</YR>
<VL>181</VL>
<NO>6</NO>
<PG>1473-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Croom-1992" NAME="Croom 1992" NOTES="&lt;p&gt;0002-9378 (Print)&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Croom CS, Banias BB, Ramos-Santos E, Devoe LD, Bezhadian A, Hiett AK</AU>
<TI>Do semiquantitative amniotic fluid indexes reflect actual volume?</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1992</YR>
<VL>167</VL>
<NO>4 Pt 1</NO>
<PG>995-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fischer-1993" MODIFIED="2008-03-18 14:27:17 +0000" MODIFIED_BY="Lynn Hampson" NAME="Fischer 1993" NOTES="&lt;p&gt;Journal Article&lt;/p&gt;" NOTES_MODIFIED="2008-03-18 14:27:17 +0000" NOTES_MODIFIED_BY="Lynn Hampson" TYPE="JOURNAL_ARTICLE">
<AU>Fischer RL, McDonnell M, Bianculli KW, Perry RL, Hediger ML, Scholl TO</AU>
<TI>Amniotic fluid volume estimation in the postdate pregnancy: a comparison of techniques</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1993</YR>
<VL>81</VL>
<NO>5 Pt 1</NO>
<PG>698-704</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="0029-7844 (Print)"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Fok-2006" NAME="Fok 2006" TYPE="JOURNAL_ARTICLE">
<AU>Fok WY, Chan LY, Lau TK</AU>
<TI>The influence of fetal position on amniotic fluid index and single deepest pocket</TI>
<SO>Ultrasound in Obstetrics and Gynecology</SO>
<YR>2006</YR>
<VL>28</VL>
<NO>2</NO>
<PG>162-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Garmel-1997" NAME="Garmel 1997" NOTES="&lt;p&gt;Journal Article&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Garmel SH, Chelmow D, Sha SJ, Roan JT, D'Alton ME</AU>
<TI>Oligohydramnios and the appropriately grown fetus</TI>
<SO>American Journal of Perinatology</SO>
<YR>1997</YR>
<VL>14</VL>
<NO>6</NO>
<PG>359-63</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="0735-1631 (Print)"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Goldstein-1988" NAME="Goldstein 1988" NOTES="&lt;p&gt;Journal Article&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Goldstein RB, Filly RA</AU>
<TI>Sonographic estimation of amniotic fluid volume. Subjective assessment versus pocket measurements</TI>
<SO>Journal of Ultrasound Medicine</SO>
<YR>1988</YR>
<VL>7</VL>
<NO>7</NO>
<PG>363-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="0278-4297 (Print)"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Gramellini-2004" NAME="Gramellini 2004" TYPE="JOURNAL_ARTICLE">
<AU>Gramellini D, Fieni S, Verrotti C, Piantelli G, Cavallotti D, Vadora E</AU>
<TI>Ultrasound evaluation of amniotic fluid volume: methods and clinical accuracy</TI>
<SO>Acta Bio-Medica de L'Ateneo Parmense</SO>
<YR>2004</YR>
<VL>75 Suppl 1</VL>
<PG>40-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hashimoto-1987" NAME="Hashimoto 1987" NOTES="&lt;p&gt;0278-4297 (Print)&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Hashimoto B, Filly RA, Belden C, Callen PW, Laros RK</AU>
<TI>Objective method of diagnosing oligohydramnios in postterm pregnancies</TI>
<SO>Journal of Ultrasound Medicine</SO>
<YR>1987</YR>
<VL>6</VL>
<NO>2</NO>
<PG>81-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2008" MODIFIED="2009-05-06 12:56:14 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2008" TYPE="OTHER">
<AU>Higgins JPT, Green S, editors</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hill-1983" NAME="Hill 1983" NOTES="&lt;p&gt;Journal Article&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Hill LM, Breckle R, Wolfgram KR, O'Brien PC</AU>
<TI>Oligohydramnios: ultrasonically detected incidence and subsequent fetal outcome</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1983</YR>
<VL>147</VL>
<NO>4</NO>
<PG>407-10</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="0002-9378 (Print)"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hinh-2005" MODIFIED="2008-03-18 14:28:05 +0000" MODIFIED_BY="Lynn Hampson" NAME="Hinh 2005" NOTES="&lt;p&gt;0020-7292 (Print)&lt;/p&gt;" NOTES_MODIFIED="2008-03-18 14:28:05 +0000" NOTES_MODIFIED_BY="Lynn Hampson" TYPE="JOURNAL_ARTICLE">
<AU>Hinh ND, Ladinsky JL</AU>
<TI>Amniotic fluid index measurements in normal pregnancy after 28 gestational weeks</TI>
<SO>International Journal of Gynecology &amp; Obstetrics</SO>
<YR>2005</YR>
<VL>91</VL>
<NO>2</NO>
<PG>132-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jaba-2005" NAME="Jaba 2005" TYPE="JOURNAL_ARTICLE">
<AU>Jaba B, Mohiuddin AS, Dey SN, Khan NA, Talukder SI</AU>
<TI>Ultrasonographic determination of amniotic fluid volume in normal pregnancy</TI>
<SO>Mymensingh Medical Journal</SO>
<YR>2005</YR>
<VL>14</VL>
<NO>2</NO>
<PG>121-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Johnson-2007" MODIFIED="2008-03-18 11:29:44 +0000" MODIFIED_BY="Sonja Henderson" NAME="Johnson 2007" TYPE="JOURNAL_ARTICLE">
<AU>Johnson JM, Chauhan SP, Ennen CS, Niederhauser A, Magann EF</AU>
<TI>A comparison of 3 criteria of oligohydramnios in identifying peripartum complications: a secondary analysis</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2007</YR>
<VL>197</VL>
<NO>2</NO>
<PG>207.e1-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kawasaki-2002" NAME="Kawasaki 2002" NOTES="&lt;p&gt;Journal Article&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Kawasaki N, Nishimura H, Yoshimura T, Okamura H</AU>
<TI>A diminished intrapartum amniotic fluid index is a predictive marker of possible adverse neonatal outcome when associated with prolonged labor</TI>
<SO>Gynecologic and Obstetric Investigation</SO>
<YR>2002</YR>
<VL>53</VL>
<NO>1</NO>
<PG>1-5</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="0378-7346 (Print)"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Locatelli-2004" NAME="Locatelli 2004" TYPE="JOURNAL_ARTICLE">
<AU>Locatelli A, Zagarella A, Toso L, Assi F, Ghidini A, Biffi A</AU>
<TI>Serial assessment of amniotic fluid index in uncomplicated term pregnancies: prognostic value of amniotic fluid reduction</TI>
<SO>Journal of Maternal-Fetal &amp; Neonatal Medicine</SO>
<YR>2004</YR>
<VL>15</VL>
<NO>4</NO>
<PG>233-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Magann-1992" NAME="Magann 1992" NOTES="&lt;p&gt;Journal Article&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Magann EF, Nolan TE, Hess LW, Martin RW, Whitworth NS, Morrison JC</AU>
<TI>Measurement of amniotic fluid volume: accuracy of ultrasonography techniques</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1992</YR>
<VL>167</VL>
<NO>6</NO>
<PG>1533-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="0002-9378 (Print)"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Magann-1999a" NAME="Magann 1999a" NOTES="&lt;p&gt;Journal Article&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Magann EF, Chauhan SP, Kinsella MJ, McNamara MF, Whitworth NS, Morrison JC</AU>
<TI>Antenatal testing among 1001 patients at high risk: the role of ultrasonographic estimate of amniotic fluid volume</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1999</YR>
<VL>180</VL>
<NO>6 Pt 1</NO>
<PG>1330-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="0002-9378 (Print)"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Magann-1999b" NAME="Magann 1999b" TYPE="JOURNAL_ARTICLE">
<AU>Magann EF, Kinsella MJ, Chauhan SP, McNamara MF, Gehring BW, Morrison JC</AU>
<TI>Does an amniotic fluid index of &lt;/=5 cm necessitate delivery in high-risk pregnancies? A case-control study</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1999</YR>
<VL>180</VL>
<PG>1354-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Magann-2000" NAME="Magann 2000" TYPE="JOURNAL_ARTICLE">
<AU>Magann EF, Isler CM, Chauhan SP, Martin JN, Jr</AU>
<TI>Amniotic fluid volume estimation and the biophysical profile: a confusion of criteria</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>2000</YR>
<VL>96</VL>
<NO>4</NO>
<PG>640-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Magann-2003" NAME="Magann 2003" TYPE="JOURNAL_ARTICLE">
<AU>Magann EF, Chauhan SP, Bofill JA, Martin JN, Jr</AU>
<TI>Comparability of the amniotic fluid index and single deepest pocket measurements in clinical practice</TI>
<SO>Australian and New Zealand Journal of Obstetrics and Gynaecology</SO>
<YR>2003</YR>
<VL>43</VL>
<NO>1</NO>
<PG>75-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Manning-1981" NAME="Manning 1981" NOTES="&lt;p&gt;Journal Article&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Manning FA, Hill LM, Platt LD</AU>
<TI>Qualitative amniotic fluid volume determination by ultrasound: antepartum detection of intrauterine growth retardation</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1981</YR>
<VL>139</VL>
<NO>3</NO>
<PG>254-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="0002-9378 (Print)"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Morris-2003" MODIFIED="2008-03-18 14:30:26 +0000" MODIFIED_BY="Lynn Hampson" NAME="Morris 2003" TYPE="JOURNAL_ARTICLE">
<AU>Morris JM, Thompson K, Smithey J, Gaffney G, Cooke I, Chamberlain P, et al</AU>
<TI>The usefulness of ultrasound assessment of amniotic fluid in predicting adverse outcome in prolonged pregnancy: a prospective blinded observational study</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>2003</YR>
<VL>110</VL>
<NO>11</NO>
<PG>989-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Myles-2002" NAME="Myles 2002" TYPE="JOURNAL_ARTICLE">
<AU>Myles TD, Santolaya-Forgas J</AU>
<TI>Normal ultrasonic evaluation of amniotic fluid in low-risk patients at term</TI>
<SO>Journal of Reproductive Medicine</SO>
<YR>2002</YR>
<VL>47</VL>
<NO>8</NO>
<PG>621-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Peedicayil-1994" NAME="Peedicayil 1994" NOTES="&lt;p&gt;Journal Article&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Peedicayil A, Mathai M, Regi A, Aseelan L, Rekha K, Jasper P</AU>
<TI>Inter- and intra-observer variation in the amniotic fluid index</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1994</YR>
<VL>84</VL>
<NO>5</NO>
<PG>848-51</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="0029-7844 (Print)"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Phelan-1987" NAME="Phelan 1987" TYPE="JOURNAL_ARTICLE">
<AU>Phelan JP, Smith CV, Broussard P, Small M</AU>
<TI>Amniotic fluid volume assessment with the four-quadrant technique at 36-42 weeks' gestation</TI>
<SO>Journal of Reproductive Medicine</SO>
<YR>1987</YR>
<VL>32</VL>
<NO>7</NO>
<PG>540-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2008" MODIFIED="2009-04-01 20:29:58 +0100" MODIFIED_BY="[Empty name]" NAME="RevMan 2008" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2008</YR>
<EN>5.0</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rogers-1999" NAME="Rogers 1999" NOTES="&lt;p&gt;0378-3782 (Print)&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Rogers MS, Wang CC</AU>
<TI>A comparison of three ultrasound estimates of intrapartum oligohydramnios for prediction of fetal hypoxia-reperfusion injury</TI>
<SO>Early Human Development</SO>
<YR>1999</YR>
<VL>56</VL>
<NO>2-3</NO>
<PG>117-26</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ross-2001" NAME="Ross 2001" TYPE="JOURNAL_ARTICLE">
<AU>Ross MG, Brace RA</AU>
<TI>National Institute of Child Health and Development Conference summary: amniotic fluid biology--basic and clinical aspects</TI>
<SO>Journal of Maternal-Fetal Medicine</SO>
<YR>2001</YR>
<VL>10</VL>
<NO>1</NO>
<PG>2-19</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="11332413"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Rutherford-1987a" NAME="Rutherford 1987a" TYPE="JOURNAL_ARTICLE">
<AU>Rutherford SE, Smith CV, Phelan JP, Kawakami K, Ahn MO</AU>
<TI>Four-quadrant assessment of amniotic fluid volume. Interobserver and intraobserver variation</TI>
<SO>Journal of Reproductive Medicine</SO>
<YR>1987</YR>
<VL>32</VL>
<PG>587-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rutherford-1987b" MODIFIED="2008-03-18 14:30:58 +0000" MODIFIED_BY="Lynn Hampson" NAME="Rutherford 1987b" TYPE="JOURNAL_ARTICLE">
<AU>Rutherford SE, Phelan JP, Smith CV, Jacobs N</AU>
<TI>The four-quadrant assessment of amniotic fluid volume: an adjunct to antepartum fetal heart rate testing</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1987</YR>
<VL>70</VL>
<PG>353-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sarno-1989" NAME="Sarno 1989" TYPE="JOURNAL_ARTICLE">
<AU>Sarno AP Jr, Ahn MO, Brar HS, Phelan JP, Platt LD</AU>
<TI>Intrapartum Doppler velocimetry, amniotic fluid volume, and fetal heart rate as predictors of subsequent fetal distress. I. An initial report</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1989</YR>
<VL>161</VL>
<PG>1508-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Seffah-1999" NAME="Seffah 1999" NOTES="&lt;p&gt;0012-835X (Print)&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Seffah JD, Armah JO</AU>
<TI>Amniotic fluid index for screening late pregnancies</TI>
<SO>East African Medical Journal</SO>
<YR>1999</YR>
<VL>76</VL>
<NO>6</NO>
<PG>348-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sherer-2002" NAME="Sherer 2002" TYPE="JOURNAL_ARTICLE">
<AU>Sherer DM</AU>
<TI>A review of amniotic fluid dynamics and the enigma of isolated oligohydramnios</TI>
<SO>American Journal of Perinatology</SO>
<YR>2002</YR>
<VL>19</VL>
<NO>5</NO>
<PG>253-66</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Williams-1993" NAME="Williams 1993" TYPE="JOURNAL_ARTICLE">
<AU>Williams K</AU>
<TI>Amniotic fluid assessment</TI>
<SO>Obstetrical &amp; Gynecological Survey</SO>
<YR>1993</YR>
<VL>48</VL>
<NO>12</NO>
<PG>795-800</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2009-05-07 14:36:02 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2009-05-07 14:36:02 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="YES" USER_DEF_1_NAME="risk status of subjects" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2009-04-07 10:22:40 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Alfirevic-1997">
<CHAR_METHODS MODIFIED="2008-03-18 11:26:51 +0000" MODIFIED_BY="Sonja Henderson">
<P>Randomised controlled trial. Women were allocated to monitoring by sealed envelopes prepared in blocks of 100. Each block was prepared by shuffling 2 sets of 50 cards which were sealed in sequentially-numbered opaque envelopes. The allocation sequence was recorded on a master list which was held separately.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-04-07 10:22:28 +0100" MODIFIED_BY="[Empty name]">
<P>500 women with singleton uncomplicated post-term pregnancies.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-04-07 10:22:29 +0100" MODIFIED_BY="[Empty name]">
<P>AFI in 250 and single deepest pocket in 250 cases.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-04-07 10:22:37 +0100" MODIFIED_BY="[Empty name]">
<P>Admission to NICU, induction of labor, caesarean section, CS for fetal distress, instrumental delivery, oligohydramnios, Apgar score &lt; 7 at 5 min, perinatal death, presence of meconium.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2009-04-07 10:22:39 +0100" MODIFIED_BY="[Empty name]">
<P>High risk.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2009-04-07 10:22:40 +0100" MODIFIED_BY="[Empty name]">
<P>UK. July 1994 to July 1995.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-04-07 10:22:52 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chauhan-2004">
<CHAR_METHODS MODIFIED="2008-03-18 11:27:03 +0000" MODIFIED_BY="Sonja Henderson">
<P>Randomised controlled trial. Randomisation was accomplished via use of a computer-generated random number table with blocked permutations. Randomisation was accomplished by opening sealed opaque envelopes containing group allocations that were prepared in blocks of 14 envelopes, 7 per allocation. When the envelope pack was reduced to 8 envelopes, a new block of 14 envelopes was supplemented. A person not directly associated with the study performed randomization and envelope preparation.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-04-07 10:22:47 +0100" MODIFIED_BY="[Empty name]">
<P>1088 pregnant women.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-04-07 10:22:48 +0100" MODIFIED_BY="[Empty name]">
<P>AFI in 530 and single deepest pocket in 558 cases.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-04-07 10:22:50 +0100" MODIFIED_BY="[Empty name]">
<P>Umbilical artery pH &lt; 7.1, CS for fetal distress and admission to NICU, oligohydramnios, non-reassuring fetal heart rate (FHR) tracing, assisted vaginal delivery, caesarean section, Apgar score &lt; 7 at 5 min, presence of meconium, perinatal death.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2009-04-07 10:22:51 +0100" MODIFIED_BY="[Empty name]">
<P>High risk.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2009-04-07 10:22:52 +0100" MODIFIED_BY="[Empty name]">
<P>USA. 1997 to 2001.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-04-24 15:50:47 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Magann-2004">
<CHAR_METHODS MODIFIED="2009-04-24 15:50:47 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial. A randomization schedule was prepared in advance using a computer-generated number table with a card sealed in an opaque envelope that assigned patients to have the amniotic fluid assessed either with AFI or single deepest pocket.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-04-07 10:22:58 +0100" MODIFIED_BY="[Empty name]">
<P>537 pregnant women.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-04-07 10:22:58 +0100" MODIFIED_BY="[Empty name]">
<P>AFI in 273 and single deepest pocket in 264 cases.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-04-07 10:22:59 +0100" MODIFIED_BY="[Empty name]">
<P>Umbilical artery pH &lt; 7.1, CS for fetal distress and admission to NICU, Apgar scores &lt; 7 at 5 min, oligohydramnios, presence of meconium.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2009-04-07 10:23:00 +0100" MODIFIED_BY="[Empty name]">
<P>High risk.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2009-04-07 10:23:01 +0100" MODIFIED_BY="[Empty name]">
<P>USA.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-04-24 15:51:28 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Moses-2004">
<CHAR_METHODS MODIFIED="2009-04-24 15:51:28 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial. Women who gave signed consent were assigned randomly to groups by a computer-generated random number table with blocked permutations. Group assignment was placed into sequentially numbered, sealed, opaque envelopes. A person who was not associated directly with the study performed randomization and envelope preparation. Women were assigned either to the AFI group or the single deepest pocket technique group. The caregivers were not aware of the group assignment or the specific measurement.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-04-07 10:23:08 +0100" MODIFIED_BY="[Empty name]">
<P>1000 pregnant women.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-04-07 10:23:09 +0100" MODIFIED_BY="[Empty name]">
<P>AFI in 499 and single deepest pocket in 501 cases.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-04-07 10:23:09 +0100" MODIFIED_BY="[Empty name]">
<P>Umbilical artery pH &lt; 7.1, CS for fetal distress and admission to NICU, oligohydramnios, Induction of labor, assisted vaginal delivery, caesarean delivery, Apgar score &lt; 7 at 5 minutes.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2009-04-07 10:23:10 +0100" MODIFIED_BY="[Empty name]">
<P>High risk.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2009-04-07 10:23:10 +0100" MODIFIED_BY="[Empty name]">
<P>USA. July 2001 to January 2003.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-04-07 10:23:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Oral-1999">
<CHAR_METHODS MODIFIED="2009-03-18 12:01:46 +0000" MODIFIED_BY="Ashraf F Nabhan">
<P>Women at their 290th day of gestation were randomly assigned to either amniotic fluid index (four-quadrant technique) or maximal vertical pocket. In both cases electronic foetal heart monitoring.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-04-07 10:23:14 +0100" MODIFIED_BY="[Empty name]">
<P>101 women with singleton uncomplicated post-term pregnancies.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-04-07 10:23:17 +0100" MODIFIED_BY="[Empty name]">
<P>AFI in 48 and single deepest pocket in 53 cases.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-04-07 10:23:18 +0100" MODIFIED_BY="[Empty name]">
<P>Admission to NICU, induction of labor, caesarean section, CS for fetal distress, oligohydramnios, Apgar score &lt; 7 at 5 min, perinatal death, presence of meconium.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2009-04-07 10:23:18 +0100" MODIFIED_BY="[Empty name]">
<P>High risk.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2009-03-18 11:33:14 +0000" MODIFIED_BY="Ashraf F Nabhan"/>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>AFI = Amniotic Fluid Index<BR/>CS = Caesarean Section<BR/>NICU = Neonatal Intensive Care Unit<BR/>
<BR/>
<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2009-04-24 15:53:37 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2009-04-24 15:53:34 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Alfirevic-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-04-24 15:53:34 +0100" MODIFIED_BY="[Empty name]">
<P>This was a randomized controlled trial comparing simple with complex antenatal fetal monitoring after 42 weeks of gestation. The study did not include a comparison between AFI and SDVP.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-03-18 11:27:36 +0000" MODIFIED_BY="Sonja Henderson" STUDY_ID="STD-Callan-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-03-18 11:27:36 +0000" MODIFIED_BY="Sonja Henderson">
<P>This trial compared curvilinear and linear transducers. It did not include data on a comparison between AFI and SDVP.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-04-24 15:53:37 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chauhan-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-04-24 15:53:37 +0100" MODIFIED_BY="[Empty name]">
<P>This was a randomized study to assess the efficacy of the amniotic fluid index as a fetal admission test. It did not include data on the SDVP.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-03-18 11:27:40 +0000" MODIFIED_BY="Sonja Henderson" STUDY_ID="STD-Magann-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-03-18 11:27:40 +0000" MODIFIED_BY="Sonja Henderson">
<P>This trial assessed the accuracy of ultrasonic techniques for the evaluation of amniotic fluid volume in twins.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>AFI = Amniotic Fluid Index<BR/>SDVP = Single Deepest Vertical Pocket</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2009-03-18 11:33:14 +0000" MODIFIED_BY="Ashraf F Nabhan" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2009-05-07 14:36:02 +0100" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2009-05-07 14:36:02 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-06 10:21:04 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Alfirevic-1997">
<DESCRIPTION>
<P>Shuffling cards.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-06 11:48:51 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chauhan-2004">
<DESCRIPTION>
<P>Computer-generated random number table with blocked permutations.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-06 11:49:04 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Magann-2004">
<DESCRIPTION>
<P>Computer-generated random number table.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-07 14:36:02 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moses-2004">
<DESCRIPTION>
<P>Computer-generated random number table.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-04-24 16:41:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Oral-1999">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2009-04-24 16:41:41 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-04-07 10:22:44 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Alfirevic-1997">
<DESCRIPTION>
<P>Adequate.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-04-07 10:22:55 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chauhan-2004">
<DESCRIPTION>
<P>Adequate.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-04-07 10:23:04 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Magann-2004">
<DESCRIPTION>
<P>Adequate.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-04-07 10:23:13 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moses-2004">
<DESCRIPTION>
<P>Adequate.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-04-24 16:41:41 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Oral-1999">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2009-04-24 16:42:07 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-04-24 16:42:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Alfirevic-1997">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-04-24 16:41:55 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chauhan-2004">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-04-24 16:41:49 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Magann-2004">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-04-24 15:53:04 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moses-2004">
<DESCRIPTION>
<P>The caregivers were not aware of the group assignment or the specific measurement</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-03-18 12:03:25 +0000" MODIFIED_BY="Ashraf F Nabhan" RESULT="UNKNOWN" STUDY_ID="STD-Oral-1999">
<DESCRIPTION>
<P>Not stated. Probably not done due to different technique.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2009-04-24 16:40:37 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-04-24 16:39:58 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Alfirevic-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-04-24 16:40:04 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chauhan-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-04-24 16:40:10 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Magann-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-04-24 16:40:17 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moses-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-04-24 16:40:37 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Oral-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2009-05-07 14:35:24 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-10-15 13:49:27 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Alfirevic-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-10-15 13:55:50 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chauhan-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-07 14:35:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Magann-2004">
<DESCRIPTION>
<P>No data provided regarding perinatal death.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-07 14:35:24 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Moses-2004">
<DESCRIPTION>
<P>No data provided regarding perinatal death.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Oral-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2009-04-24 15:47:41 +0100" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2009-04-24 15:47:41 +0100" MODIFIED_BY="[Empty name]" NO="1" READONLY="YES">
<TITLE MODIFIED="2009-04-24 15:47:41 +0100" MODIFIED_BY="[Empty name]">AFI vs SDVP: summary of findings table</TITLE>
<TABLE COLS="7" ROWS="9">
<TR>
<TD COLSPAN="7">
<P>
<B>Amniotic fluid index compared to Single deepest vertical pocket for pregnant women to prevent adverse pregnancy outcome</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B> Patient or population:</B> pregnant women to prevent adverse pregnancy outcome</P>
<P>
<B> Settings:</B> Inpatient</P>
<P>
<B> Intervention:</B> Amniotic fluid index</P>
<P>
<B>Comparison: </B>Single deepest vertical pocket</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P> </P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Single deepest vertical pocket</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Amniotic fluid index</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P> </P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P> </P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P> </P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P> </P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Admission to neonatal intensive care unit</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Low risk population<SUP>1</SUP>
</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>RR 1.04 </B>
<BR/>(0.85 to 1.26)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>3226<BR/>(5 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>48 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>50 per 1000</B>
<BR/>(41 to 60)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>High risk population<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>349 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>363 per 1000</B>
<BR/>(297 to 440)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Perinatal deaths</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>-<BR/>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Only 3 trials of the included 5 trials reported this critical outcome measure. No cases of perinatal deaths occurred in the 3 trials including 1689 women<BR/>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Umbilical artery pH less than 7.1</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Low risk population<SUP>1</SUP>
</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>RR 1.1 </B>
<BR/>(0.74 to 1.65)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>2625<BR/>(3 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>31 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>34 per 1000</B>
<BR/>(23 to 51)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>High risk population<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>38 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>42 per 1000</B>
<BR/>(28 to 63)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Rate of diagnosis of oligohydramnios</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Low risk population<SUP>1</SUP>
</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>RR 2.39 </B>
<BR/>(1.73 to 3.28)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>3226<BR/>(5 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>4</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>24 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>57 per 1000</B>
<BR/>(42 to 79)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>High risk population<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>174 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>416 per 1000</B>
<BR/>(301 to 571)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Caesarean delivery</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Low risk population<SUP>1</SUP>
</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>RR 1.09 </B>
<BR/>(0.92 to 1.29)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>3226<BR/>(5 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>66 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>72 per 1000</B>
<BR/>(61 to 85)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>High risk population<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>277 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>302 per 1000</B>
<BR/>(255 to 357)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Rate of induction of labor</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Low risk population<SUP>1</SUP>
</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>RR 1.92 </B>
<BR/>(1.5 to 2.46)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>2138<BR/>(4 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>
<B>high</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>12 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>23 per 1000</B>
<BR/>(18 to 30)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>High risk population<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>302 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>580 per 1000</B>
<BR/>(453 to 743)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Caesarean delivery for fetal distress</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Low risk population<SUP>1</SUP>
</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>RR 1.46 </B>
<BR/>(1.08 to 1.96)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>3226<BR/>(5 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>25 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>37 per 1000</B>
<BR/>(27 to 49)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>High risk population<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>68 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>99 per 1000</B>
<BR/>(73 to 133)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<BR/>CI: Confidence interval; <B>RR:</B> Risk ratio; </P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect. <BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> Low and High risk represent risks in control groups of included studies.</P>
<P>
<SUP>2</SUP> Amniotic fluid volume is an indirect measure of outcome.</P>
<P>
<SUP>3</SUP> Confidence intervals include no difference.</P>
<P>
<SUP>4</SUP> There is unexplained significant heterogeneity </P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2009-05-06 12:01:43 +0100" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2009-05-06 12:01:43 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>AFI versus SDVP: Primary outcome measures</NAME>
<DICH_OUTCOME CHI2="1.0460061532818576" CI_END="1.2639533512451113" CI_START="0.8528074955629427" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0382239122577228" ESTIMABLE="YES" EVENTS_1="157" EVENTS_2="150" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.10173104572588648" LOG_CI_START="-0.06914899116539351" LOG_EFFECT_SIZE="0.016291027280246468" METHOD="MH" MODIFIED="2009-05-06 12:01:43 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9027415519261035" P_Q="0.0" P_Z="0.7086197592990651" Q="0.0" RANDOM="NO" SCALE="24.8628216154093" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1600" TOTAL_2="1626" WEIGHT="100.0" Z="0.3737104382855148">
<NAME>Admission to neonatal intensive care unit</NAME>
<GROUP_LABEL_1>AFI</GROUP_LABEL_1>
<GROUP_LABEL_2>SDVP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AFI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SDVP</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.9541746192355585" CI_START="0.25289727852062466" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.597055844162257" LOG_CI_START="-0.597055844162257" LOG_EFFECT_SIZE="0.0" MODIFIED="2008-02-27 11:05:18 +0000" MODIFIED_BY="[Empty name]" ORDER="45" O_E="0.0" SE="0.7014271166700072" STUDY_ID="STD-Alfirevic-1997" TOTAL_1="250" TOTAL_2="250" VAR="0.492" WEIGHT="2.654314003145842"/>
<DICH_DATA CI_END="2.048523850036619" CI_START="0.7881624260436609" EFFECT_SIZE="1.2706571242680547" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="29" LOG_CI_END="0.3114410246128127" LOG_CI_START="-0.1033842730365942" LOG_EFFECT_SIZE="0.10402837578810925" ORDER="42" O_E="0.0" SE="0.24367043325760213" STUDY_ID="STD-Chauhan-2004" TOTAL_1="530" TOTAL_2="558" VAR="0.05937528004394753" WEIGHT="18.748532274058636"/>
<DICH_DATA CI_END="1.2223296461304882" CI_START="0.7650577422293433" EFFECT_SIZE="0.967032967032967" ESTIMABLE="YES" EVENTS_1="92" EVENTS_2="92" LOG_CI_END="0.0871883451774569" LOG_CI_START="-0.11630578551930686" LOG_EFFECT_SIZE="-0.01455872017092497" ORDER="44" O_E="0.0" SE="0.1195334596834717" STUDY_ID="STD-Magann-2004" TOTAL_1="273" TOTAL_2="264" VAR="0.014288247983900156" WEIGHT="62.07239339200277"/>
<DICH_DATA CI_END="1.805864112018558" CI_START="0.6056850121711276" EFFECT_SIZE="1.0458416833667334" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="24" LOG_CI_END="0.2566850673391469" LOG_CI_START="-0.21775317293057214" LOG_EFFECT_SIZE="0.01946594720428738" ORDER="43" O_E="0.0" SE="0.27868737084159856" STUDY_ID="STD-Moses-2004" TOTAL_1="499" TOTAL_2="501" VAR="0.07766665066660267" WEIGHT="15.894032250837304"/>
<DICH_DATA CI_END="17.171475202927898" CI_START="0.07100054091857497" EFFECT_SIZE="1.1041666666666667" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.234807607040379" LOG_CI_START="-1.1487383425899753" LOG_EFFECT_SIZE="0.04303463222520185" MODIFIED="2009-03-18 12:17:23 +0000" MODIFIED_BY="Ashraf F Nabhan" ORDER="43" O_E="0.0" SE="1.4001066895556085" STUDY_ID="STD-Oral-1999" TOTAL_1="48" TOTAL_2="53" VAR="1.9602987421383649" WEIGHT="0.6307280799554476"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2009-03-18 12:16:41 +0000" MODIFIED_BY="Ashraf F Nabhan" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="828" TOTAL_2="861" WEIGHT="0.0" Z="0.0">
<NAME>Perinatal deaths</NAME>
<GROUP_LABEL_1>AFI</GROUP_LABEL_1>
<GROUP_LABEL_2>SDVP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AFI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SDVP</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="5" O_E="0.0" SE="0.0" STUDY_ID="STD-Alfirevic-1997" TOTAL_1="250" TOTAL_2="250" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="6" O_E="0.0" SE="0.0" STUDY_ID="STD-Chauhan-2004" TOTAL_1="530" TOTAL_2="558" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-03-18 12:16:41 +0000" MODIFIED_BY="Ashraf F Nabhan" ORDER="42" O_E="0.0" SE="0.0" STUDY_ID="STD-Oral-1999" TOTAL_1="48" TOTAL_2="53" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2009-05-06 12:01:29 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>AFI versus SDVP: Secondary outcome measures</NAME>
<DICH_OUTCOME CHI2="9.763908237487922" CI_END="3.280646858786568" CI_START="1.7340222257145175" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="2.38510263256247" ESTIMABLE="YES" EVENTS_1="347" EVENTS_2="153" I2="59.032798110061634" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.5159594838043511" LOG_CI_START="0.23905465971649534" LOG_EFFECT_SIZE="0.3775070717604232" METHOD="MH" MODIFIED="2009-05-06 12:01:12 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.044598107734469594" P_Q="0.0" P_Z="9.087924534004818E-8" Q="0.0" RANDOM="YES" SCALE="24.075615285432452" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0666197948972106" TOTALS="YES" TOTAL_1="1600" TOTAL_2="1626" WEIGHT="100.0" Z="5.344076377122656">
<NAME>Rate of diagnosis of oligohydramnios</NAME>
<GROUP_LABEL_1>AFI</GROUP_LABEL_1>
<GROUP_LABEL_2>SDVP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AFI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SDVP</GRAPH_LABEL_2>
<DICH_DATA CI_END="9.981289281926484" CI_START="1.7393655890274182" EFFECT_SIZE="4.166666666666667" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="6" LOG_CI_END="0.9991866426763305" LOG_CI_START="0.24039087390045752" LOG_EFFECT_SIZE="0.619788758288394" ORDER="7" O_E="0.0" SE="0.44572039067858077" STUDY_ID="STD-Alfirevic-1997" TOTAL_1="250" TOTAL_2="250" VAR="0.19866666666666666" WEIGHT="9.97289302717269"/>
<DICH_DATA CI_END="2.219048670355572" CI_START="1.1905988642240946" EFFECT_SIZE="1.6254220456802384" ESTIMABLE="YES" EVENTS_1="88" EVENTS_2="57" LOG_CI_END="0.34616682770972523" LOG_CI_START="0.07576546391920869" LOG_EFFECT_SIZE="0.21096614581446696" ORDER="8" O_E="0.0" SE="0.1588350995988874" STUDY_ID="STD-Chauhan-2004" TOTAL_1="530" TOTAL_2="558" VAR="0.02522858886458848" WEIGHT="28.804791052121672"/>
<DICH_DATA CI_END="2.906726468462435" CI_START="1.5818418982553069" EFFECT_SIZE="2.1442904921165793" ESTIMABLE="YES" EVENTS_1="102" EVENTS_2="46" LOG_CI_END="0.4634041653010047" LOG_CI_START="0.19916307451783244" LOG_EFFECT_SIZE="0.33128361990941857" ORDER="9" O_E="0.0" SE="0.15521652474053016" STUDY_ID="STD-Magann-2004" TOTAL_1="273" TOTAL_2="264" VAR="0.024092169552527607" WEIGHT="29.165651066895652"/>
<DICH_DATA CI_END="4.111706069364634" CI_START="2.1369634246192195" EFFECT_SIZE="2.964214142570856" ESTIMABLE="YES" EVENTS_1="124" EVENTS_2="42" LOG_CI_END="0.6140220609931547" LOG_CI_START="0.32979708902322624" LOG_EFFECT_SIZE="0.4719095750081904" ORDER="10" O_E="0.0" SE="0.1669551554714381" STUDY_ID="STD-Moses-2004" TOTAL_1="499" TOTAL_2="501" VAR="0.027874023938492067" WEIGHT="27.998376352359795"/>
<DICH_DATA CI_END="19.78357749858936" CI_START="0.9860170358892554" EFFECT_SIZE="4.416666666666667" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="2" LOG_CI_END="1.29630482858623" LOG_CI_START="-0.0061155814799013246" LOG_EFFECT_SIZE="0.6450946235531643" MODIFIED="2009-03-18 12:20:17 +0000" MODIFIED_BY="Ashraf F Nabhan" ORDER="46" O_E="0.0" SE="0.7650481959578526" STUDY_ID="STD-Oral-1999" TOTAL_1="48" TOTAL_2="53" VAR="0.5852987421383647" WEIGHT="4.0582885014501935"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.0665302693344985" CI_END="1.6461404295369015" CI_START="0.7358148161078104" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1005700874761803" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="44" I2="3.2194190582034756" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="0.21646688140572562" LOG_CI_START="-0.13323147161622237" LOG_EFFECT_SIZE="0.04161770489475163" METHOD="MH" NO="2" P_CHI2="0.35584333573541693" P_Q="0.0" P_Z="0.640849210308605" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1302" TOTAL_2="1323" WEIGHT="100.00000000000001" Z="0.466511792280646">
<NAME>Umbilical artery pH less than 7.1</NAME>
<GROUP_LABEL_1>AFI</GROUP_LABEL_1>
<GROUP_LABEL_2>SDVP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AFI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SDVP</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.7412875475427003" CI_START="0.4317222114384812" EFFECT_SIZE="0.8670366259711432" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="17" LOG_CI_END="0.2408704942646351" LOG_CI_START="-0.36479560699112745" LOG_EFFECT_SIZE="-0.061962556363246206" ORDER="11" O_E="0.0" SE="0.3557712659731888" STUDY_ID="STD-Chauhan-2004" TOTAL_1="530" TOTAL_2="558" VAR="0.12657319369216544" WEIGHT="37.90384232691988"/>
<DICH_DATA CI_END="3.700780575358325" CI_START="0.8187178025087974" EFFECT_SIZE="1.7406593406593407" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="10" LOG_CI_END="0.5682933359094582" LOG_CI_START="-0.08686576604469597" LOG_EFFECT_SIZE="0.24071378493238113" ORDER="12" O_E="0.0" SE="0.38484369957772874" STUDY_ID="STD-Magann-2004" TOTAL_1="273" TOTAL_2="264" VAR="0.14810467310467312" WEIGHT="23.268891927056114"/>
<DICH_DATA CI_END="1.8491247916148912" CI_START="0.48289227926341316" EFFECT_SIZE="0.9449487209713545" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="17" LOG_CI_END="0.2669662213165147" LOG_CI_START="-0.3161497382735014" LOG_EFFECT_SIZE="-0.024591758478493323" ORDER="13" O_E="0.0" SE="0.3425252011337278" STUDY_ID="STD-Moses-2004" TOTAL_1="499" TOTAL_2="501" VAR="0.1173235134117007" WEIGHT="38.82726574602401"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.308514031437363" CI_END="1.8904941491670975" CI_START="0.6974715327448808" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1482882268249575" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="28" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="0.2765753376158376" LOG_CI_START="-0.15647351339359175" LOG_EFFECT_SIZE="0.06005091211112294" METHOD="MH" MODIFIED="2009-05-06 12:01:29 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.6792194134283869" P_Q="0.0" P_Z="0.5867328239785572" Q="0.0" RANDOM="NO" SCALE="24.075615285432452" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1600" TOTAL_2="1626" WEIGHT="100.0" Z="0.543576664398162">
<NAME>Apgar score less than seven at five minutes</NAME>
<GROUP_LABEL_1>AFI</GROUP_LABEL_1>
<GROUP_LABEL_2>SDVP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AFI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SDVP</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.4114299951480764" CI_START="0.2931322059729366" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.53293646369072" LOG_CI_START="-0.5329364636907199" LOG_EFFECT_SIZE="0.0" ORDER="14" O_E="0.0" SE="0.6260990336999411" STUDY_ID="STD-Alfirevic-1997" TOTAL_1="250" TOTAL_2="250" VAR="0.392" WEIGHT="17.852067527242255"/>
<DICH_DATA CI_END="5.569882058535683" CI_START="0.7960322280043295" EFFECT_SIZE="2.1056603773584905" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="6" LOG_CI_END="0.7458459991468996" LOG_CI_START="-0.09906934914535787" LOG_EFFECT_SIZE="0.3233883250007709" ORDER="15" O_E="0.0" SE="0.49630745798529896" STUDY_ID="STD-Chauhan-2004" TOTAL_1="530" TOTAL_2="558" VAR="0.24632109285182932" WEIGHT="20.8711671825847"/>
<DICH_DATA CI_END="1.9205110746315095" CI_START="0.41489818145422563" EFFECT_SIZE="0.8926458157227388" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="13" LOG_CI_END="0.28341681586854006" LOG_CI_START="-0.38205846872881377" LOG_EFFECT_SIZE="-0.0493208264301369" ORDER="16" O_E="0.0" SE="0.3909034763282719" STUDY_ID="STD-Magann-2004" TOTAL_1="273" TOTAL_2="264" VAR="0.1528055278055278" WEIGHT="47.19328689324601"/>
<DICH_DATA CI_END="3.9885581213535946" CI_START="0.1123248681282622" EFFECT_SIZE="0.6693386773547094" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.600815924981766" LOG_CI_START="-0.949524082605417" LOG_EFFECT_SIZE="-0.17435407881182544" ORDER="17" O_E="0.0" SE="0.9106773947635184" STUDY_ID="STD-Moses-2004" TOTAL_1="499" TOTAL_2="501" VAR="0.8293333173332692" WEIGHT="10.689818035312664"/>
<DICH_DATA CI_END="17.171475202927898" CI_START="0.07100054091857497" EFFECT_SIZE="1.1041666666666667" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.234807607040379" LOG_CI_START="-1.1487383425899753" LOG_EFFECT_SIZE="0.04303463222520185" MODIFIED="2009-03-18 12:21:03 +0000" MODIFIED_BY="Ashraf F Nabhan" ORDER="47" O_E="0.0" SE="1.4001066895556085" STUDY_ID="STD-Oral-1999" TOTAL_1="48" TOTAL_2="53" VAR="1.9602987421383649" WEIGHT="3.3936603616143697"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.7435912628327119" CI_END="1.3037037965669775" CI_START="0.9049060091951028" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0861534881055843" ESTIMABLE="YES" EVENTS_1="203" EVENTS_2="191" I2="0.0" I2_Q="0.0" ID="CMP-002.04" LOG_CI_END="0.11517893025409147" LOG_CI_START="-0.04339652776471205" LOG_EFFECT_SIZE="0.03589120124468969" METHOD="MH" MODIFIED="2009-03-18 12:22:30 +0000" MODIFIED_BY="Ashraf F Nabhan" NO="4" P_CHI2="0.9458464264468354" P_Q="0.0" P_Z="0.3749618146434661" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1600" TOTAL_2="1626" WEIGHT="100.0" Z="0.887217513735695">
<NAME>Presence of meconium</NAME>
<GROUP_LABEL_1>AFI</GROUP_LABEL_1>
<GROUP_LABEL_2>SDVP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AFI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SDVP</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.3858132120474387" CI_START="0.721597969557941" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="56" LOG_CI_END="0.14170469748804193" LOG_CI_START="-0.1417046974880419" LOG_EFFECT_SIZE="0.0" ORDER="18" O_E="0.0" SE="0.16647608150808244" STUDY_ID="STD-Alfirevic-1997" TOTAL_1="250" TOTAL_2="250" VAR="0.02771428571428571" WEIGHT="29.65654340787897"/>
<DICH_DATA CI_END="1.4784694878924571" CI_START="0.7733410395143762" EFFECT_SIZE="1.0692806603773586" ESTIMABLE="YES" EVENTS_1="65" EVENTS_2="64" LOG_CI_END="0.16981236614541456" LOG_CI_START="-0.11162894215389825" LOG_EFFECT_SIZE="0.029091711995758145" ORDER="19" O_E="0.0" SE="0.165320017651961" STUDY_ID="STD-Chauhan-2004" TOTAL_1="530" TOTAL_2="558" VAR="0.027330708236444696" WEIGHT="33.020941189445075"/>
<DICH_DATA CI_END="2.9940304945812475" CI_START="0.6121846158886158" EFFECT_SIZE="1.353846153846154" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="10" LOG_CI_END="0.47625621937407414" LOG_CI_START="-0.21311758835944805" LOG_EFFECT_SIZE="0.13156931550731307" ORDER="20" O_E="0.0" SE="0.4049415871180546" STUDY_ID="STD-Magann-2004" TOTAL_1="273" TOTAL_2="264" VAR="0.163977688977689" WEIGHT="5.3845679371847295"/>
<DICH_DATA CI_END="1.675941870528163" CI_START="0.8139035834150861" EFFECT_SIZE="1.1679276921189317" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="49" LOG_CI_END="0.22425895119959055" LOG_CI_START="-0.08942703942392351" LOG_EFFECT_SIZE="0.0674159558878335" ORDER="21" O_E="0.0" SE="0.1842607036629485" STUDY_ID="STD-Moses-2004" TOTAL_1="499" TOTAL_2="501" VAR="0.033952006914364924" WEIGHT="25.897576530930312"/>
<DICH_DATA CI_END="2.0771389598709717" CI_START="0.49320400096241446" EFFECT_SIZE="1.0121527777777777" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" LOG_CI_END="0.3174655516561601" LOG_CI_START="-0.3069734089845561" LOG_EFFECT_SIZE="0.005246071335801998" MODIFIED="2009-03-18 12:22:30 +0000" MODIFIED_BY="Ashraf F Nabhan" ORDER="48" O_E="0.0" SE="0.36679853650306327" STUDY_ID="STD-Oral-1999" TOTAL_1="48" TOTAL_2="53" VAR="0.13454116638078903" WEIGHT="6.040370934560922"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.738638475354402" CI_END="1.3629844538288198" CI_START="0.9307502013052684" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1263205825949933" ESTIMABLE="YES" EVENTS_1="192" EVENTS_2="174" I2="0.0" I2_Q="0.0" ID="CMP-002.05" LOG_CI_END="0.13449090230946262" LOG_CI_START="-0.031166861179129295" LOG_EFFECT_SIZE="0.051662020565166625" METHOD="MH" MODIFIED="2009-03-18 12:23:28 +0000" MODIFIED_BY="Ashraf F Nabhan" NO="5" P_CHI2="0.43370105202033227" P_Q="0.0" P_Z="0.22153052794709804" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1350" TOTAL_2="1376" WEIGHT="100.00000000000001" Z="1.2224685103063972">
<NAME>Non-reassuring fetal heart rate tracing</NAME>
<GROUP_LABEL_1>AFI</GROUP_LABEL_1>
<GROUP_LABEL_2>SDVP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AFI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SDVP</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.4546757163790263" CI_START="0.8372068829461721" EFFECT_SIZE="1.1035689929529438" ESTIMABLE="YES" EVENTS_1="87" EVENTS_2="83" LOG_CI_END="0.16276618900318307" LOG_CI_START="-0.07716720984451447" LOG_EFFECT_SIZE="0.042799489579334285" ORDER="22" O_E="0.0" SE="0.14093806617261664" STUDY_ID="STD-Chauhan-2004" TOTAL_1="530" TOTAL_2="558" VAR="0.019863538496476867" WEIGHT="46.98600456569589"/>
<DICH_DATA CI_END="2.229588316186982" CI_START="0.9437140001198566" EFFECT_SIZE="1.4505494505494505" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="30" LOG_CI_END="0.3482246798580929" LOG_CI_START="-0.025159602088580417" LOG_EFFECT_SIZE="0.16153253888475624" ORDER="23" O_E="0.0" SE="0.21932777549748025" STUDY_ID="STD-Magann-2004" TOTAL_1="273" TOTAL_2="264" VAR="0.048104673104673104" WEIGHT="17.723645953208333"/>
<DICH_DATA CI_END="1.3475994996267193" CI_START="0.6726403427297983" EFFECT_SIZE="0.9520765669269574" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="58" LOG_CI_END="0.12956084105248195" LOG_CI_START="-0.17221708870215718" LOG_EFFECT_SIZE="-0.02132812382483761" ORDER="24" O_E="0.0" SE="0.17726584976271942" STUDY_ID="STD-Moses-2004" TOTAL_1="499" TOTAL_2="501" VAR="0.03142318149209901" WEIGHT="33.63349423106895"/>
<DICH_DATA CI_END="7.293377465600371" CI_START="0.4643421124651661" EFFECT_SIZE="1.8402777777777777" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.862928690867973" LOG_CI_START="-0.33316192718485665" LOG_EFFECT_SIZE="0.2648833818415582" MODIFIED="2009-03-18 12:23:28 +0000" MODIFIED_BY="Ashraf F Nabhan" ORDER="49" O_E="0.0" SE="0.70258954978828" STUDY_ID="STD-Oral-1999" TOTAL_1="48" TOTAL_2="53" VAR="0.4936320754716981" WEIGHT="1.6568552500268303"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.229410651619536" CI_END="2.4594705508293426" CI_START="1.5029858185134706" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.9226412455130613" ESTIMABLE="YES" EVENTS_1="154" EVENTS_2="80" I2="29.06813154094571" I2_Q="0.0" ID="CMP-002.06" LOG_CI_END="0.3908416267778942" LOG_CI_START="0.17695488280221003" LOG_EFFECT_SIZE="0.2838982547900521" METHOD="MH" MODIFIED="2009-03-18 12:24:44 +0000" MODIFIED_BY="Ashraf F Nabhan" NO="6" P_CHI2="0.23773391775510466" P_Q="0.0" P_Z="1.9605748725079395E-7" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1070" TOTAL_2="1068" WEIGHT="100.0" Z="5.20303731142437">
<NAME>Rate of induction of labor</NAME>
<GROUP_LABEL_1>AFI</GROUP_LABEL_1>
<GROUP_LABEL_2>SDVP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AFI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SDVP</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.290844256665107" CI_START="1.1523619690091393" EFFECT_SIZE="1.9473684210526316" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="19" LOG_CI_END="0.5173073292492658" LOG_CI_START="0.0615889169790664" LOG_EFFECT_SIZE="0.289448123114166" ORDER="25" O_E="0.0" SE="0.26769125121003756" STUDY_ID="STD-Alfirevic-1997" TOTAL_1="250" TOTAL_2="250" VAR="0.07165860597439544" WEIGHT="23.794748380904046"/>
<DICH_DATA CI_END="2.8288174531084467" CI_START="1.4259965031410538" EFFECT_SIZE="2.0084530853761624" ESTIMABLE="YES" EVENTS_1="81" EVENTS_2="39" LOG_CI_END="0.4516049228314617" LOG_CI_START="0.15411846053098952" LOG_EFFECT_SIZE="0.30286169168122556" ORDER="26" O_E="0.0" SE="0.17474502053703522" STUDY_ID="STD-Magann-2004" TOTAL_1="273" TOTAL_2="264" VAR="0.030535822202488867" WEIGHT="49.66043046388031"/>
<DICH_DATA CI_END="7.894035806139619" CI_START="1.280501140654481" EFFECT_SIZE="3.17935871743487" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="6" LOG_CI_END="0.8972990919573414" LOG_CI_START="0.10737996966874076" LOG_EFFECT_SIZE="0.5023395308130412" ORDER="27" O_E="0.0" SE="0.4640024025950416" STUDY_ID="STD-Moses-2004" TOTAL_1="499" TOTAL_2="501" VAR="0.21529822961397108" WEIGHT="7.499102805518603"/>
<DICH_DATA CI_END="2.053754589928958" CI_START="0.6701601426030733" EFFECT_SIZE="1.1731770833333333" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="16" LOG_CI_END="0.31254854704742313" LOG_CI_START="-0.17382140515232114" LOG_EFFECT_SIZE="0.06936357094755094" MODIFIED="2009-03-18 12:24:44 +0000" MODIFIED_BY="Ashraf F Nabhan" ORDER="50" O_E="0.0" SE="0.28569611749222196" STUDY_ID="STD-Oral-1999" TOTAL_1="48" TOTAL_2="53" VAR="0.0816222715501295" WEIGHT="19.045718349697037"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.079458130667865" CI_END="1.271329319096207" CI_START="0.9152935601864536" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0787212515960678" ESTIMABLE="YES" EVENTS_1="240" EVENTS_2="228" I2="0.0" I2_Q="0.0" ID="CMP-002.07" LOG_CI_END="0.10425806270260646" LOG_CI_START="-0.03843959323208155" LOG_EFFECT_SIZE="0.03290923473526242" METHOD="MH" NO="7" P_CHI2="0.7820351704859807" P_Q="0.0" P_Z="0.36598371127148965" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1552" TOTAL_2="1573" WEIGHT="99.99999999999999" Z="0.9040220656380038">
<NAME>Assisted vaginal delivery</NAME>
<GROUP_LABEL_1>AFI</GROUP_LABEL_1>
<GROUP_LABEL_2>SDVP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AFI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SDVP</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.4395458548031788" CI_START="0.6946635264610759" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="47" LOG_CI_END="0.15822550330288948" LOG_CI_START="-0.15822550330288945" LOG_EFFECT_SIZE="0.0" ORDER="28" O_E="0.0" SE="0.18588488773798073" STUDY_ID="STD-Alfirevic-1997" TOTAL_1="250" TOTAL_2="250" VAR="0.0345531914893617" WEIGHT="20.864787609851565"/>
<DICH_DATA CI_END="1.449574820240464" CI_START="0.9310649609192844" EFFECT_SIZE="1.16174365647365" ESTIMABLE="YES" EVENTS_1="128" EVENTS_2="116" LOG_CI_END="0.16124063650989134" LOG_CI_START="-0.03102001699441212" LOG_EFFECT_SIZE="0.06511030975773964" ORDER="29" O_E="0.0" SE="0.11293485957401161" STUDY_ID="STD-Chauhan-2004" TOTAL_1="530" TOTAL_2="558" VAR="0.012754282507001724" WEIGHT="50.17080500053481"/>
<DICH_DATA CI_END="1.9760600752433863" CI_START="0.6258612983007238" EFFECT_SIZE="1.1120879120879121" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="20" LOG_CI_END="0.29580014366765406" LOG_CI_START="-0.20352190330228065" LOG_EFFECT_SIZE="0.046139120182686726" ORDER="30" O_E="0.0" SE="0.29330424207413497" STUDY_ID="STD-Magann-2004" TOTAL_1="273" TOTAL_2="264" VAR="0.08602737841868277" WEIGHT="9.027436930923534"/>
<DICH_DATA CI_END="1.4005036495877852" CI_START="0.6269944099497649" EFFECT_SIZE="0.9370741482965932" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="45" LOG_CI_END="0.14628424489380418" LOG_CI_START="-0.20273633116097897" LOG_EFFECT_SIZE="-0.02822604313358741" ORDER="31" O_E="0.0" SE="0.20501641405429477" STUDY_ID="STD-Moses-2004" TOTAL_1="499" TOTAL_2="501" VAR="0.042031730031682035" WEIGHT="19.936970458690077"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.04828557653779164" CI_END="1.4376814176418136" CI_START="0.7975313408152843" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0707922247929775" ESTIMABLE="YES" EVENTS_1="79" EVENTS_2="77" I2="0.0" I2_Q="0.0" ID="CMP-002.08" LOG_CI_END="0.15766265942043062" LOG_CI_START="-0.09825224134201342" LOG_EFFECT_SIZE="0.029705209039208633" METHOD="MH" NO="8" P_CHI2="0.826073812817694" P_Q="0.0" P_Z="0.6491064293690494" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="803" TOTAL_2="822" WEIGHT="100.0" Z="0.4550039071318245">
<NAME>Assisted vaginal delivery for fetal distress</NAME>
<GROUP_LABEL_1>AFI</GROUP_LABEL_1>
<GROUP_LABEL_2>SDVPl</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AFI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SDVP</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.4759800397809089" CI_START="0.7951603024558934" EFFECT_SIZE="1.0833470057424117" ESTIMABLE="YES" EVENTS_1="71" EVENTS_2="69" LOG_CI_END="0.16908048440326734" LOG_CI_START="-0.09954530976604803" LOG_EFFECT_SIZE="0.034767587318609634" ORDER="32" O_E="0.0" SE="0.15779212121418243" STUDY_ID="STD-Chauhan-2004" TOTAL_1="530" TOTAL_2="558" VAR="0.024898353517271238" WEIGHT="89.20613445398764"/>
<DICH_DATA CI_END="2.538936716950357" CI_START="0.3683245640134907" EFFECT_SIZE="0.967032967032967" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="8" LOG_CI_END="0.4046518762097725" LOG_CI_START="-0.43376931655162243" LOG_EFFECT_SIZE="-0.01455872017092497" ORDER="33" O_E="0.0" SE="0.492492758879882" STUDY_ID="STD-Magann-2004" TOTAL_1="273" TOTAL_2="264" VAR="0.24254911754911757" WEIGHT="10.793865546012357"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.8438981900696945" CI_END="1.2866877662961616" CI_START="0.9171615797084705" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0863243458229916" ESTIMABLE="YES" EVENTS_1="229" EVENTS_2="211" I2="31.55253787964612" I2_Q="0.0" ID="CMP-002.09" LOG_CI_END="0.1094731717480975" LOG_CI_START="-0.03755414634297698" LOG_EFFECT_SIZE="0.03595951270256025" METHOD="MH" MODIFIED="2009-03-18 12:18:38 +0000" MODIFIED_BY="Ashraf F Nabhan" NO="9" P_CHI2="0.21111338246984546" P_Q="0.0" P_Z="0.33769753864052277" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1600" TOTAL_2="1626" WEIGHT="100.00000000000001" Z="0.9587245515145836">
<NAME>Caesarean delivery</NAME>
<GROUP_LABEL_1>AFI</GROUP_LABEL_1>
<GROUP_LABEL_2>SDVP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AFI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SDVP</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.1442651444087484" CI_START="0.9459961088773187" EFFECT_SIZE="1.4242424242424243" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="33" LOG_CI_END="0.33127848607389304" LOG_CI_START="-0.024110649958233015" LOG_EFFECT_SIZE="0.15358391805783" ORDER="34" O_E="0.0" SE="0.20875733770986626" STUDY_ID="STD-Alfirevic-1997" TOTAL_1="250" TOTAL_2="250" VAR="0.04357962604771115" WEIGHT="15.654446729471198"/>
<DICH_DATA CI_END="1.6345773628995233" CI_START="0.6781272219677199" EFFECT_SIZE="1.0528301886792453" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="37" LOG_CI_END="0.21340548012303695" LOG_CI_START="-0.16868882144945754" LOG_EFFECT_SIZE="0.0223583293367897" ORDER="35" O_E="0.0" SE="0.22444408414098013" STUDY_ID="STD-Chauhan-2004" TOTAL_1="530" TOTAL_2="558" VAR="0.050375146905883364" WEIGHT="17.100250688777304"/>
<DICH_DATA CI_END="1.5277748691639215" CI_START="0.909824213722919" EFFECT_SIZE="1.1789853981634804" ESTIMABLE="YES" EVENTS_1="89" EVENTS_2="73" LOG_CI_END="0.18405936190765826" LOG_CI_START="-0.04104250920059443" LOG_EFFECT_SIZE="0.07150842635353191" ORDER="36" O_E="0.0" SE="0.13222595336122037" STUDY_ID="STD-Magann-2004" TOTAL_1="273" TOTAL_2="264" VAR="0.017483702742283624" WEIGHT="35.209916920222504"/>
<DICH_DATA CI_END="1.1083974541808064" CI_START="0.5399019384256711" EFFECT_SIZE="0.7735799467788035" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="61" LOG_CI_END="0.04469551960342991" LOG_CI_START="-0.2676851132658175" LOG_EFFECT_SIZE="-0.11149479683119377" ORDER="37" O_E="0.0" SE="0.1834939300564672" STUDY_ID="STD-Moses-2004" TOTAL_1="499" TOTAL_2="501" VAR="0.03367002236756767" WEIGHT="28.87913357565902"/>
<DICH_DATA CI_END="3.517156073799397" CI_START="0.5730157546462307" EFFECT_SIZE="1.4196428571428572" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.5461916405620131" LOG_CI_START="-0.24183343726147313" LOG_EFFECT_SIZE="0.1521791016502699" MODIFIED="2009-03-18 12:18:38 +0000" MODIFIED_BY="Ashraf F Nabhan" ORDER="44" O_E="0.0" SE="0.46288983150056207" STUDY_ID="STD-Oral-1999" TOTAL_1="48" TOTAL_2="53" VAR="0.21426699610661873" WEIGHT="3.1562520858699803"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.7928142829250273" CI_END="1.9605597716710501" CI_START="1.080468293723168" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.455445866818723" ESTIMABLE="YES" EVENTS_1="100" EVENTS_2="69" I2="0.0" I2_Q="0.0" ID="CMP-002.10" LOG_CI_END="0.2923800871928224" LOG_CI_START="0.033612027060902216" LOG_EFFECT_SIZE="0.16299605712686233" METHOD="MH" MODIFIED="2009-03-18 12:19:13 +0000" MODIFIED_BY="Ashraf F Nabhan" NO="10" P_CHI2="0.43477099857310264" P_Q="0.0" P_Z="0.013544080037269795" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1600" TOTAL_2="1626" WEIGHT="100.0" Z="2.4691331799436083">
<NAME>Caesarean delivery for fetal distress</NAME>
<GROUP_LABEL_1>AFI</GROUP_LABEL_1>
<GROUP_LABEL_2>SDVP</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours AFI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours SDVP</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.185885209659766" CI_START="0.9555923776335773" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="10" LOG_CI_END="0.6217873144243363" LOG_CI_START="-0.019727323096373876" LOG_EFFECT_SIZE="0.3010299956639812" ORDER="38" O_E="0.0" SE="0.37682887362833545" STUDY_ID="STD-Alfirevic-1997" TOTAL_1="250" TOTAL_2="250" VAR="0.14200000000000002" WEIGHT="14.54654061482209"/>
<DICH_DATA CI_END="2.440899625128308" CI_START="0.593131012160062" EFFECT_SIZE="1.2032345013477088" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="14" LOG_CI_END="0.38754992069158956" LOG_CI_START="-0.22684936806263672" LOG_EFFECT_SIZE="0.08035027631447643" ORDER="39" O_E="0.0" SE="0.3609011835397617" STUDY_ID="STD-Chauhan-2004" TOTAL_1="530" TOTAL_2="558" VAR="0.13024966428040075" WEIGHT="19.841053559187483"/>
<DICH_DATA CI_END="3.318560980135051" CI_START="1.1271786354705187" EFFECT_SIZE="1.934065934065934" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="18" LOG_CI_END="0.5209498024188738" LOG_CI_START="0.0519927485672387" LOG_EFFECT_SIZE="0.28647127549305623" ORDER="40" O_E="0.0" SE="0.27546769480730565" STUDY_ID="STD-Magann-2004" TOTAL_1="273" TOTAL_2="264" VAR="0.07588245088245088" WEIGHT="26.622607292825233"/>
<DICH_DATA CI_END="1.7437654161919076" CI_START="0.5780778118985839" EFFECT_SIZE="1.0040080160320641" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="24" LOG_CI_END="0.24148806012303892" LOG_CI_START="-0.23801369963532734" LOG_EFFECT_SIZE="0.0017371802438558048" ORDER="41" O_E="0.0" SE="0.28166170725405565" STUDY_ID="STD-Moses-2004" TOTAL_1="499" TOTAL_2="501" VAR="0.07933331733326933" WEIGHT="34.84187408062187"/>
<DICH_DATA CI_END="6.245630177628827" CI_START="0.3470327588989287" EFFECT_SIZE="1.4722222222222223" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7955762647852872" LOG_CI_START="-0.45962952711828375" LOG_EFFECT_SIZE="0.1679733688335018" MODIFIED="2009-03-18 12:19:13 +0000" MODIFIED_BY="Ashraf F Nabhan" ORDER="45" O_E="0.0" SE="0.7373140955330354" STUDY_ID="STD-Oral-1999" TOTAL_1="48" TOTAL_2="53" VAR="0.543632075471698" WEIGHT="4.147924452543329"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK/>
<APPENDICES MODIFIED="2008-03-18 14:33:25 +0000" MODIFIED_BY="Lynn Hampson">
<APPENDIX ID="APP-01" MODIFIED="2008-03-18 14:33:25 +0000" MODIFIED_BY="Lynn Hampson" NO="1">
<TITLE MODIFIED="2008-03-18 14:07:00 +0000" MODIFIED_BY="Lynn Hampson">Search strategies</TITLE>
<APPENDIX_BODY MODIFIED="2008-03-18 14:33:25 +0000" MODIFIED_BY="Lynn Hampson">
<P>
<B>CENTRAL (<I>The Cochrane Library)</I>
</B>
</P>
<P>#1 Pregnancy/<BR/>#2 Pregnancy Complications/<BR/>#3 Fetus/<BR/>#4 Fetal Monitoring/<BR/>#5 pregnan*<BR/>#6 antepart*<BR/>#7 prenatal*<BR/>#8 antenatal*<BR/>#9 perinatal*<BR/>#10 intrapart*<BR/>#11 amniotic near fluid<BR/>#12 amniotic near volume<BR/>#13 vertical near pocket<BR/>#14 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10<BR/>#15 #11 or #12 or #13<BR/>#16 #14 and #15</P>
<P>
<B>MEDLINE</B>
</P>
<P>1.randomised controlled trial.pt.<BR/>2.randomised controlled trials/<BR/>3.controlled clinical trial.pt.<BR/>4.random allocation/<BR/>5.double blind method/<BR/>6.single-blind method/<BR/>7.or/1-6<BR/>8.clinical trial.pt.<BR/>9.exp clinical trials/<BR/>10.(clin$ adj25 trial$).tw.<BR/>11.((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).tw.<BR/>12.placebos/<BR/>13.placebo$.tw.<BR/>14.random$.tw.<BR/>15.research design/<BR/>16.or/8-15<BR/>17.comparative study/<BR/>18.exp evaluation studies/<BR/>19.follow up studies/<BR/>20.prospective studies/<BR/>21.(control$ or prospectiv$ or volunteer$).tw.<BR/>22.or/17-21<BR/>23.animal/ not (human/ and animal/)<BR/>24.7 or 16 or 22<BR/>25.24 not 23<BR/>26.exp pregnancy/<BR/>27.exp fetus/<BR/>28.exp infant, newborn/<BR/>29.exp pregnancy complications/<BR/>30.or/ 26-30<BR/>31 25 and 31<BR/>32. amniotic fluid index.tw<BR/>33. amniotic fluid pocket.tw<BR/>34. oligohydramnios.tw<BR/>35. umbilical artery pH.tw<BR/>36. fetal monitoring.tw<BR/>37. or/ 32-36<BR/>38 37 and 31</P>
<P>
<B>mRCT (searched using each term individually)</B>
</P>
<P>1 Amniotic fluid index<BR/>2 Single deepest vertical pocket<BR/>3 Oligohydramnios<BR/>4 Fetal monitoring</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>